{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T11:47:28Z","timestamp":1785757648709,"version":"3.56.0"},"reference-count":598,"publisher":"MDPI AG","issue":"8","license":[{"start":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T00:00:00Z","timestamp":1785283200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. Cardiovasc. Dev. Dis.","JCDD"],"abstract":"<jats:p>Internal and external stress exerted by forces such as oxidative, xenobiotic, radiant, ischemic, mechanical, metabolic, neurohormonal, infectious, immunoinflammatory, emotional and psychological increases the risk of cardiovascular morbidity and mortality. Initiation and propagation of the explosive self-amplifying chain reaction of lipid peroxidation chain reaction (LPO) generates atherogenic and inflammatory toxic reactive oxygen species that cause cardiovascular tissue lesion that are the ultimate determinants of cardiovascular disease risk (CVD-R). Because the LPO toxins, cellular stress sensors and defenses, inter- and intracellular signaling, and pathogenic lesions are closely similar among these stressors, simultaneous exposure to multiple stresses can amplify LPO to accelerate accumulation of pathogenic lesions synergistically. Numerous blood tests measure LPO-derived toxins, stress-responsive metabolism and cytokines, which are used clinically as surrogate biomarkers of CVD-R. They can predict population risks quite well, but prediction of individual patient CVD-R using multiplex biomarker panels is hampered by lack of true independence between biomarkers, lack of understanding of their relative hierarchy in disease etiology or progression, and interference from comorbid diseases or acute-phase reactions. We present this historical review of landmark studies that led to the current clinical paradigms of CVD-R prediction to provide mechanistic and clinical context that will aid the development of integrated etiological biomarkers that reflect the multiple types of stress that promote CVD-R.<\/jats:p>","DOI":"10.3390\/jcdd13080358","type":"journal-article","created":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T13:53:31Z","timestamp":1785333211000},"page":"358","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Biomarkers of Cardiovascular Stress: A Historical Review"],"prefix":"10.3390","volume":"13","author":[{"given":"Harshit","family":"Khosla","sequence":"first","affiliation":[{"name":"Division of Hematology Oncology, Houston and McGovern Medical School, University of Texas Health Science Center, Houston, TX 77030, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5934-2695","authenticated-orcid":false,"given":"Jonathan","family":"Kopel","sequence":"additional","affiliation":[{"name":"Department of Neurology, MedStar Georgetown University Hospital, Washington, DC 20007, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mostafa","family":"Abohelwa","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Texas Tech University Health Sciences Center, Lubbock, TX 79430, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meenakshi","family":"Awasthi","sequence":"additional","affiliation":[{"name":"Department of Emergency Medicine, Houston and McGovern Medical School, University of Texas Health Science Center, Houston, TX 77030, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Virginia","family":"Mohlere","sequence":"additional","affiliation":[{"name":"Division of Hematology Oncology, Houston and McGovern Medical School, University of Texas Health Science Center, Houston, TX 77030, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4361-4558","authenticated-orcid":false,"given":"Sharda P.","family":"Singh","sequence":"additional","affiliation":[{"name":"Division of Hematology and Oncology, Department of Internal Medicine, Texas Tech University Health Sciences Center, Lubbock, TX 79430, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott","family":"Shurmur","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Texas Tech University Health Sciences Center, Lubbock, TX 79430, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Ansari","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Texas Tech University Health Sciences Center, Lubbock, TX 79430, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yogesh","family":"Awasthi","sequence":"additional","affiliation":[{"name":"Department of Molecular Biology and Immunology, University North Texas Health Science Center, Fort Worth, TX 76107, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanjay","family":"Awasthi","sequence":"additional","affiliation":[{"name":"Department of Hematology and Oncology, Texas Tech University Health Sciences Center, Lubbock, TX 79430, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,7,29]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Biomarkers Definitions Working Group, Atkinson, A.J., Colburn, W.A., DeGruttola, V.G., DeMets, D.L., Downing, G.J., Hoth, D.F., Oates, J.A., Peck, C.C., and Schooley, R.T. (2001). Biomarkers and surrogate endpoints: Preferred definitions and conceptual framework. Clin. Pharmacol. Ther., 69, 89\u201395.","DOI":"10.1067\/mcp.2001.113989"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"468","DOI":"10.3109\/10253890.2011.606341","article-title":"Chronic stress, metabolism, and metabolic syndrome","volume":"14","author":"Tamashiro","year":"2011","journal-title":"Stress"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1016\/j.freeradbiomed.2013.09.014","article-title":"Role of oxidative stress in impaired insulin signaling associated with exercise-induced muscle damage","volume":"65","author":"Aoi","year":"2013","journal-title":"Free Radic. Biol. Med."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"41213","DOI":"10.1074\/jbc.M106838200","article-title":"Accelerated Metabolism and Exclusion of 4-Hydroxynonenal through Induction of RLIP76 and hGST5.8 Is an Early Adaptive Response of Cells to Heat and Oxidative Stress","volume":"276","author":"Cheng","year":"2001","journal-title":"J. Biol. Chem."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1158\/1055-9965.EPI-10-0987","article-title":"Relationship between biomarkers of cigarette smoke exposure and biomarkers of inflammation, oxidative stress, and platelet activation in adult cigarette smokers","volume":"20","author":"Liu","year":"2011","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1016\/j.fct.2011.12.031","article-title":"Alterations in oxidative stress biomarkers associated with mild hyperlipidemia and smoking","volume":"50","author":"Miri","year":"2012","journal-title":"Food Chem. Toxicol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1161\/01.CIR.0000089129.51288.BA","article-title":"Connective tissue growth factor is a mediator of angiotensin II-induced fibrosis","volume":"108","author":"Ruperez","year":"2003","journal-title":"Circulation"},{"key":"ref_8","unstructured":"Awasthi, Y.C., Singhal, S.S., and Awasthi, S. (1996). Mechanisms of anti-carcinogenic effects of antioxidant nutrients. Nutrition and Cancer Prevention, CRC Press."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"572491","DOI":"10.1155\/2014\/572491","article-title":"Isoprostanes and neuroprostanes as biomarkers of oxidative stress in neurodegenerative diseases","volume":"2014","author":"Miller","year":"2014","journal-title":"Oxid. Med. Cell Longev."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1089\/ars.2012.5148","article-title":"Updating the mitochondrial free radical theory of aging: An integrated view, key aspects, and confounding concepts","volume":"19","author":"Barja","year":"2013","journal-title":"Antioxid. Redox Signal."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1152\/physrev.1998.78.2.547","article-title":"The free radical theory of aging matures","volume":"78","author":"Beckman","year":"1998","journal-title":"Physiol. Rev."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1161\/01.ATV.0000080379.05071.22","article-title":"Association of high coronary heart disease risk status with circulating oxidized LDL in the well-functioning elderly: Findings from the Health, Aging, and Body Composition study","volume":"23","author":"Holvoet","year":"2003","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_13","first-page":"585","article-title":"Association of polymorphisms in FADS gene with age-related changes in serum phospholipid polyunsaturated fatty acids and oxidative stress markers in middle-aged nonobese men","volume":"8","author":"Hong","year":"2013","journal-title":"Clin. Interv. Aging"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1111\/nyas.12214","article-title":"Resveratrol in mammals: Effects on aging biomarkers, age-related diseases, and life span","volume":"1290","author":"Marchal","year":"2013","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1111\/acel.12073","article-title":"Impaired mitochondrial fatty acid oxidation and insulin resistance in aging: Novel protective role of glutathione","volume":"12","author":"Nguyen","year":"2013","journal-title":"Aging Cell"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1042\/CS20060033","article-title":"Atorvastatin normalizes endothelial function in healthy smokers","volume":"111","author":"Agewall","year":"2006","journal-title":"Clin. Sci."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/0005-2760(95)00092-Q","article-title":"Gas-phase cigarette smoke inhibits plasma lecithin-cholesterol acyltransferase activity by modification of the enzyme\u2019s free thiols","volume":"1258","author":"Bielicki","year":"1995","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1002\/jbt.2570100302","article-title":"Inhibition of lecithin: Cholesterol acyltransferase activity in human blood plasma by cigarette smoke extract and reactive aldehydes","volume":"10","author":"Chen","year":"1995","journal-title":"J. Biochem. Toxicol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1161\/01.ATV.0000058402.34138.11","article-title":"Obesity and systemic oxidative stress: Clinical correlates of oxidative stress in the Framingham Study","volume":"23","author":"Keaney","year":"2003","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.atherosclerosis.2007.12.058","article-title":"Relation of smoking status to a panel of inflammatory markers: The framingham offspring","volume":"201","author":"Levitzky","year":"2008","journal-title":"Atherosclerosis"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1111\/j.1365-2125.2005.02568.x","article-title":"Reduction of oxidative stress and modulation of autoantibodies against modified low-density lipoprotein after rosuvastatin therapy","volume":"61","author":"Resch","year":"2006","journal-title":"Br. J. Clin. Pharmacol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1161\/01.CIR.0000136581.59584.0E","article-title":"C-reactive protein, the metabolic syndrome, and prediction of cardiovascular events in the Framingham Offspring Study","volume":"110","author":"Rutter","year":"2004","journal-title":"Circulation"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"714","DOI":"10.2337\/db09-0911","article-title":"A central role of RLIP76 in regulation of glycemic control","volume":"59","author":"Awasthi","year":"2010","journal-title":"Diabetes"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"353","DOI":"10.2337\/diabetes.48.2.353","article-title":"An insulin sensitizer improves the free radical defense system potential and insulin sensitivity in high fructose-fed rats","volume":"48","author":"Faure","year":"1999","journal-title":"Diabetes"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1139\/y2012-090","article-title":"Understanding the in-vivo relevance of S-nitrosothiols in insulin action","volume":"90","author":"Fernandes","year":"2012","journal-title":"Can. J. Physiol. Pharmacol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.atherosclerosis.2013.06.017","article-title":"Endothelium-specific insulin resistance leads to accelerated atherosclerosis in areas with disturbed flow patterns: A role for reactive oxygen species","volume":"230","author":"Gage","year":"2013","journal-title":"Atherosclerosis"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1042\/bj3490579","article-title":"Effect of inhibition of glutathione synthesis on insulin action: In vivo and in vitro studies using buthionine sulfoximine","volume":"349","author":"Khamaisi","year":"2000","journal-title":"Biochem. J."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1016\/S0735-1097(01)01659-X","article-title":"Coronary endothelial dysfunction in the insulin-resistant state is linked to abnormal pteridine metabolism and vascular oxidative stress","volume":"38","author":"Shinozaki","year":"2001","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/s10555-007-9043-5","article-title":"Linking stress-signaling, glutathione metabolism, signaling pathways and xenobiotic transporters","volume":"26","author":"Yadav","year":"2007","journal-title":"Cancer Metastasis Rev."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1089\/ars.2010.3794","article-title":"The peroxide dilemma: Opposing and mediating insulin action","volume":"15","author":"Szypowska","year":"2011","journal-title":"Antioxid. Redox Signal."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/0049-3848(95)00244-8","article-title":"Evidence for a relationship between plasminogen activator inhibitor-1 and gamma glutamyl transferase","volume":"81","author":"Bastard","year":"1996","journal-title":"Thromb. Res."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"e30","DOI":"10.1038\/nutd.2012.3","article-title":"Relation of depot-specific adipose inflammation to insulin resistance in human obesity","volume":"2","author":"Bigornia","year":"2012","journal-title":"Nutr. Diabetes"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1038\/sj.ijo.0801361","article-title":"Glycemic status and soluble tumor necrosis factor receptor levels in relation to plasma leptin concentrations among normal weight and overweight US men","volume":"24","author":"Chu","year":"2000","journal-title":"Int. J. Obes."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.jcjd.2013.01.007","article-title":"Insulin resistance of protein metabolism in type 2 diabetes and impact on dietary needs: A review","volume":"37","author":"Gougeon","year":"2013","journal-title":"Can. J. Diabetes"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1161\/01.ATV.0000063608.43095.E2","article-title":"Obesity and oxidative stress: A direct link to CVD?","volume":"23","author":"Higdon","year":"2003","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"2409","DOI":"10.1172\/JCI117936","article-title":"Increased adipose tissue expression of tumor necrosis factor-alpha in human obesity and insulin resistance","volume":"95","author":"Hotamisligil","year":"1995","journal-title":"J. Clin. Investig."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0014-2999(99)00407-0","article-title":"F2-isoprostane evidence of oxidant stress in the insulin resistant, obese Zucker rat: Effects of vitamin E","volume":"377","author":"Laight","year":"1999","journal-title":"Eur. J. Pharmacol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1210\/en.2007-0920","article-title":"Resistance to the nitric oxide\/cyclic guanosine 5\u2019-monophosphate\/protein kinase G pathway in vascular smooth muscle cells from the obese Zucker rat, a classical animal model of insulin resistance: Role of oxidative stress","volume":"149","author":"Russo","year":"2008","journal-title":"Endocrinology"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"2498","DOI":"10.1073\/pnas.95.5.2498","article-title":"Fatty acid-induced \u03b2 cell apoptosis: A link between obesity and diabetes","volume":"95","author":"Shimabukuro","year":"1998","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"23394","DOI":"10.1074\/jbc.M113.480194","article-title":"RLIP76 Protein Knockdown Attenuates Obesity Due to a High-fat Diet","volume":"288","author":"Singhal","year":"2013","journal-title":"J. Biol. Chem."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0026-0495(00)80082-7","article-title":"Oxidative stress and glycemic regulation","volume":"49","author":"Ceriello","year":"2000","journal-title":"Metabolism"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1161\/ATVBAHA.110.207340","article-title":"Serum gamma-glutamyl transferase and risk of heart failure in the community","volume":"30","author":"Dhingra","year":"2010","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1097\/HJH.0b013e328346d72c","article-title":"Association between ADRA1A gene and the metabolic syndrome: Candidate genes and functional counterpart in the PAMELA population","volume":"29","author":"Grassi","year":"2011","journal-title":"J. Hypertens."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1161\/01.CIR.0000019884.36724.D9","article-title":"Metabolic Syndrome: Pathophysiology and Implications for Management of Cardiovascular Disease","volume":"106","author":"Reaven","year":"2002","journal-title":"Circulation"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.amjcard.2008.03.057","article-title":"Comparison effect of atorvastatin (10 versus 80 mg) on biomarkers of inflammation and oxidative stress in subjects with metabolic syndrome","volume":"102","author":"Singh","year":"2008","journal-title":"Am. J. Cardiol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1097\/MED.0b013e3283444b09","article-title":"Obesity, insulin resistance and free fatty acids","volume":"18","author":"Boden","year":"2011","journal-title":"Curr. Opin. Endocrinol. Diabetes Obes."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"2338","DOI":"10.2337\/diabetes.52.9.2338","article-title":"Intramuscular heat shock protein 72 and heme oxygenase-1 mRNA are reduced in patients with type 2 diabetes: Evidence that insulin resistance is associated with a disturbed antioxidant defense mechanism","volume":"52","author":"Bruce","year":"2003","journal-title":"Diabetes"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1016\/S0026-0495(98)90357-2","article-title":"Influence of reduced glutathione infusion on glucose metabolism in patients with non\u2014Insulin-dependent diabetes mellitus","volume":"47","author":"Bravi","year":"1998","journal-title":"Metabolism"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1089\/ars.2013.5182","article-title":"Hypothalamic apelin\/reactive oxygen species signaling controls hepatic glucose metabolism in the onset of diabetes","volume":"20","author":"Drougard","year":"2014","journal-title":"Antioxid. Redox Signal."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"68","DOI":"10.5551\/jat.13.68","article-title":"Probucol and atorvastatin decrease urinary 8-hydroxy-2\u2019-deoxyguanosine in patients with diabetes and hypercholesterolemia","volume":"13","author":"Endo","year":"2006","journal-title":"J. Atheroscler. Thromb."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1210\/er.2001-0039","article-title":"Oxidative stress and stress-activated signaling pathways: A unifying hypothesis of type 2 diabetes","volume":"23","author":"Evans","year":"2002","journal-title":"Endocr. Rev."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1097\/HJH.0000000000000101","article-title":"Erythropoietin-induced hypertension and vascular injury in mice overexpressing human endothelin-1: Exercise attenuated hypertension, oxidative stress, inflammation and immune response","volume":"32","author":"Barhoumi","year":"2014","journal-title":"J. Hypertens."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"5341","DOI":"10.1210\/jc.2003-030724","article-title":"Effects of bezafibrate and simvastatin on endothelial activation and lipid peroxidation in hypercholesterolemia: Evidence of different vascular protection by different lipid-lowering treatments","volume":"88","author":"Desideri","year":"2003","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.1016\/j.freeradbiomed.2006.09.001","article-title":"Systemic elevations of free radical oxidation products of arachidonic acid are associated with angiographic evidence of coronary artery disease","volume":"41","author":"Shishehbor","year":"2006","journal-title":"Free Radic. Biol. Med."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"383","DOI":"10.2147\/DDDT.S10812","article-title":"Rosuvastatin, inflammation, C-reactive protein, JUPITER, and primary prevention of cardiovascular disease\u2014A perspective","volume":"4","author":"Kones","year":"2010","journal-title":"Drug Des. Dev. Ther."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"440","DOI":"10.4065\/mcp.2009.0517","article-title":"Using apolipoprotein B to manage dyslipidemic patients: Time for a change?","volume":"85","author":"Harper","year":"2010","journal-title":"Mayo Clin. Proc."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1210\/jcem.87.2.8057","article-title":"Clinical review 141: Lipids and atherosclerosis: Lessons learned from randomized controlled trials of lipid lowering and other relevant studies","volume":"87","author":"Kreisberg","year":"2002","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1016\/j.jacc.2005.07.006","article-title":"The forgotten majority: Unfinished business in cardiovascular risk reduction","volume":"46","author":"Libby","year":"2005","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1161\/CIRCRESAHA.114.302355","article-title":"Atherosclerotic plaque destabilization: Mechanisms, models, and therapeutic strategies","volume":"114","author":"Weber","year":"2014","journal-title":"Circ. Res."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1038\/325826a0","article-title":"Structure of co-crystals of tropomyosin and troponin","volume":"325","author":"White","year":"1987","journal-title":"Nature"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"4226","DOI":"10.1016\/S0021-9258(18)62075-7","article-title":"Reconstitution of troponin activity from three protein components","volume":"246","author":"Greaser","year":"1971","journal-title":"J. Biol. Chem."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/0022-2836(82)90540-X","article-title":"Troponin and its interactions with tropomyosin. An electron microscope study","volume":"162","author":"Flicker","year":"1982","journal-title":"J. Mol. Biol."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1146\/annurev-biophys-042910-155359","article-title":"Actin structure and function","volume":"40","author":"Dominguez","year":"2011","journal-title":"Annu. Rev. Biophys."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1038\/278714a0","article-title":"Distribution of polymorphic forms of troponin components and tropomyosin in skeletal muscle","volume":"278","author":"Dhoot","year":"1979","journal-title":"Nature"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1038\/nature01780","article-title":"Structure of the core domain of human cardiac troponin in the Ca(2+)-saturated form","volume":"424","author":"Takeda","year":"2003","journal-title":"Nature"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1172\/JCI103055","article-title":"Transaminase activity in human blood","volume":"34","author":"Karmen","year":"1955","journal-title":"J. Clin. Investig."},{"key":"ref_67","first-page":"117","article-title":"The de ritis ratio: The test of time","volume":"34","author":"Botros","year":"2013","journal-title":"Clin. Biochem. Rev."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/0009-8981(57)90027-X","article-title":"An enzymic test for the diagnosis of viral hepatitis; the transaminase serum activities","volume":"2","author":"Coltorti","year":"1957","journal-title":"Clin. Chim. Acta"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1126\/science.120.3117.497","article-title":"Serum glutamic oxaloacetic transaminase activity in human acute transmural myocardial infarction","volume":"120","author":"Ladue","year":"1954","journal-title":"Science"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1097\/00000441-195906000-00011","article-title":"Lactic dehydrogenase versus glutamic oxalacetic acid transaminase as a diagnostic test for myocardial infarction","volume":"237","author":"Freeman","year":"1959","journal-title":"Am. J. Med. Sci."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1056\/NEJM195611222552103","article-title":"Serum enzymes\u2014Serum lactic dehydrogenase in myocardial infarction","volume":"255","author":"White","year":"1956","journal-title":"N. Engl. J. Med."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1136\/hrt.23.3.236","article-title":"Serum Lactic Dehydrogenase Estimations in Myocardial Infarction","volume":"23","author":"Stewart","year":"1961","journal-title":"Br. Heart J."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1002\/clc.4960091202","article-title":"\u201cFlipped\u201d lactic dehydrogenase pattern in acute coronary insufficiency","volume":"9","author":"Weinberger","year":"1986","journal-title":"Clin. Cardiol."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.7326\/0003-4819-61-6-1015","article-title":"Serum Creatine Phosphokinase (CPK) Activity in Disorders of Heart and Skeletal Muscle","volume":"61","author":"Hess","year":"1964","journal-title":"Ann. Intern. Med."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1136\/hrt.43.5.514","article-title":"Serum creatine kinase B subunit activity in diagnosis of acute myocardial infarction","volume":"43","author":"Ljungdahl","year":"1980","journal-title":"Br. Heart J."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1503\/cmaj\/051291","article-title":"Troponin: The biomarker of choice for the detection of cardiac injury","volume":"173","author":"Babuin","year":"2005","journal-title":"CMAJ"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1161\/hs0102.101544","article-title":"Creatine kinase-MB elevation after stroke is not cardiac in origin: Comparison with troponin T levels","volume":"33","author":"Ay","year":"2002","journal-title":"Stroke"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1161\/01.STR.10.5.548","article-title":"Serum cardiac enzymes in stroke","volume":"10","author":"Norris","year":"1979","journal-title":"Stroke"},{"key":"ref_79","first-page":"146","article-title":"Diagnostic and Differential Diagnostic Significance of Laboratory Markers in Crayfish-Associated Rhabdomyolysis","volume":"48","author":"Liu","year":"2018","journal-title":"Ann. Clin. Lab. Sci."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1373\/clinchem.2003.026708","article-title":"Rates of positive cardiac troponin I and creatine kinase MB mass among patients hospitalized for suspected acute coronary syndromes","volume":"50","author":"Lin","year":"2004","journal-title":"Clin. Chem."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1136\/ard.59.9.750","article-title":"Serum skeletal troponin I in inflammatory muscle disease: Relation to creatine kinase, CKMB and cardiac troponin I","volume":"59","author":"Kiely","year":"2000","journal-title":"Ann. Rheum. Dis."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1159\/000505724","article-title":"False-Positive Elevation of CK-MB Levels with Chest Pain in Lung Adenocarcinoma","volume":"13","author":"Ota","year":"2020","journal-title":"Case Rep. Oncol."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/0014-4827(78)90149-0","article-title":"The localization of the different forms of troponin I in skeletal and cardiac muscle cells","volume":"117","author":"Dhoot","year":"1978","journal-title":"Exp. Cell Res."},{"key":"ref_84","doi-asserted-by":"crossref","unstructured":"Sheng, J.J., and Jin, J.P. (2014). Gene regulation, alternative splicing, and posttranslational modification of troponin subunits in cardiac development and adaptation: A focused review. Front. Physiol., 5.","DOI":"10.3389\/fphys.2014.00165"},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/0014-5793(90)81234-F","article-title":"Molecular cloning of human cardiac troponin I using polymerase chain reaction","volume":"270","author":"Vallins","year":"1990","journal-title":"FEBS Lett."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/0161-5890(92)90109-B","article-title":"New monoclonal antibodies as probes for human cardiac troponin I: Epitopic analysis with synthetic peptides","volume":"29","author":"Larue","year":"1992","journal-title":"Mol. Immunol."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1042\/bj1710251","article-title":"Troponin I from human skeletal and cardiac muscles","volume":"171","author":"Cummins","year":"1978","journal-title":"Biochem. J."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1093\/clinchem\/43.3.458","article-title":"Improved troponin T ELISA specific for cardiac troponin T isoform: Assay development and analytical and clinical validation","volume":"43","author":"Hallermayer","year":"1997","journal-title":"Clin. Chem."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1023\/A:1005397501968","article-title":"Troponin T: Genetics, properties and function","volume":"19","author":"Perry","year":"1998","journal-title":"J. Muscle Res. Cell Motil."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1093\/clinchem\/38.3.386","article-title":"Development and in vitro characterization of a new immunoassay of cardiac troponin T","volume":"38","author":"Katus","year":"1992","journal-title":"Clin. Chem."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1056\/NEJMoa0903515","article-title":"Sensitive troponin I assay in early diagnosis of acute myocardial infarction","volume":"361","author":"Keller","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1016\/j.jacc.2012.12.026","article-title":"Prognostic value of cardiac troponin I measured with a highly sensitive assay in patients with stable coronary artery disease","volume":"61","author":"Omland","year":"2013","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1093\/clinchem\/hvaa281","article-title":"Myocardial Injury and the Release of Troponins I and T in the Blood of Patients","volume":"67","author":"Katrukha","year":"2021","journal-title":"Clin. Chem."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1515\/cclm-2016-0933","article-title":"The 99th percentile of reference population for cTnI and cTnT assay: Methodology, pathophysiology and clinical implications","volume":"55","author":"Clerico","year":"2017","journal-title":"Clin. Chem. Lab. Med."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/S0009-9120(96)00105-1","article-title":"Release kinetics of serum cardiac troponin I in ischemic myocardial injury","volume":"29","author":"Bertinchant","year":"1996","journal-title":"Clin. Biochem."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.ijcard.2015.05.079","article-title":"Early rule-out and rule-in of myocardial infarction using sensitive cardiac Troponin I","volume":"195","author":"Druey","year":"2015","journal-title":"Int. J. Cardiol."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.1056\/NEJM199712043372302","article-title":"Emergency room triage of patients with acute chest pain by means of rapid testing for cardiac troponin T or troponin I","volume":"337","author":"Hamm","year":"1997","journal-title":"N. Engl. J. Med."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/S0735-1097(97)00485-3","article-title":"Time to positivity of a rapid bedside assay for cardiac-specific troponin T predicts prognosis in acute coronary syndromes: A Thrombolysis in Myocardial Infarction (TIMI) 11A substudy","volume":"31","author":"Antman","year":"1998","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1056\/NEJMoa0900428","article-title":"Early diagnosis of myocardial infarction with sensitive cardiac troponin assays","volume":"361","author":"Reichlin","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"2813","DOI":"10.1253\/circj.CJ-11-0598","article-title":"Heart fatty acid-binding protein offers similar diagnostic performance to high-sensitivity troponin T in emergency room patients presenting with chest pain","volume":"75","author":"Inoue","year":"2011","journal-title":"Circ. J."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1016\/j.jacc.2013.02.078","article-title":"Validation of high-sensitivity troponin I in a 2-h diagnostic strategy to assess 30-day outcomes in emergency department patients with possible acute coronary syndrome","volume":"62","author":"Cullen","year":"2013","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1213\/ANE.0000000000002240","article-title":"High-Sensitivity Cardiac Troponin T Improves the Diagnosis of Perioperative MI","volume":"125","author":"Brown","year":"2017","journal-title":"Anesth. Analg."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/S0140-6736(18)31923-8","article-title":"High-sensitivity troponin in the evaluation of patients with suspected acute coronary syndrome: A stepped-wedge, cluster-randomised controlled trial","volume":"392","author":"Shah","year":"2018","journal-title":"Lancet"},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1016\/j.jacc.2019.12.036","article-title":"Risk Stratification Using High-Sensitivity Cardiac Troponin T in Patients with Suspected Acute Coronary Syndrome","volume":"75","author":"Chapman","year":"2020","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"e001769","DOI":"10.1136\/openhrt-2021-001769","article-title":"Implementation of an early rule-out pathway for myocardial infarction using a high-sensitivity cardiac troponin T assay","volume":"8","author":"Sandeman","year":"2021","journal-title":"Open Heart"},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1016\/j.jcmg.2018.01.021","article-title":"High-Sensitivity Troponin I and Coronary Computed Tomography in Symptomatic Outpatients with Suspected CAD: Insights from the PROMISE Trial","volume":"12","author":"Januzzi","year":"2019","journal-title":"JACC Cardiovasc. Imaging"},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.jacc.2013.08.1643","article-title":"Association of contemporary sensitive troponin I levels at baseline and change at 1 year with long-term coronary events following myocardial infarction or unstable angina: Results from the LIPID Study (Long-Term Intervention with Pravastatin in Ischaemic Disease)","volume":"63","author":"White","year":"2014","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1136\/bmj.313.7052.262","article-title":"Prospective study of the role of cardiac troponin T in patients admitted with unstable angina","volume":"313","author":"Stubbs","year":"1996","journal-title":"BMJ"},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1016\/j.jacc.2013.05.059","article-title":"Elevated cardiac troponin T is associated with higher mortality and amputation rates in patients with peripheral arterial disease","volume":"63","author":"Linnemann","year":"2014","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1056\/NEJM199610313351801","article-title":"Cardiac troponin T levels for risk stratification in acute myocardial ischemia. GUSTO IIA Investigators","volume":"335","author":"Ohman","year":"1996","journal-title":"N. Engl. J. Med."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1056\/NEJM199610313351802","article-title":"Cardiac-specific troponin I levels to predict the risk of mortality in patients with acute coronary syndromes","volume":"335","author":"Antman","year":"1996","journal-title":"N. Engl. J. Med."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1016\/S0735-1097(02)02119-8","article-title":"Prospective analysis of creatine kinase muscle-brain fraction and comparison with troponin T to predict cardiac risk and benefit of an invasive strategy in patients with non-ST-elevation acute coronary syndromes","volume":"40","author":"Kleiman","year":"2002","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1016\/S0735-1097(99)00080-7","article-title":"Admission risk assessment by cardiac troponin T in unstable coronary artery disease: Additional prognostic information from continuous ST segment monitoring. TRIM study group. Thrombin Inhibition in Myocardial Ischemia","volume":"33","author":"Andersen","year":"1999","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/S0735-1097(02)02824-3","article-title":"Troponin T and quantitative ST-segment depression offer complementary prognostic information in the risk stratification of acute coronary syndrome patients","volume":"41","author":"Kaul","year":"2003","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1136\/hrt.2003.020479","article-title":"Long term risk stratification of patients with acute coronary syndromes: Characteristics of troponin T testing and continuous ST segment monitoring","volume":"90","author":"Andersen","year":"2004","journal-title":"Heart"},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1016\/j.ahj.2010.03.005","article-title":"Early dynamic risk stratification with baseline troponin levels and 90-min ST-segment resolution to predict 30-day cardiovascular mortality in ST-segment elevation myocardial infarction: Analysis from CLopidogrel as Adjunctive ReperfusIon TherapY (CLARITY)-Thrombolysis in Myocardial Infarction (TIMI) 28","volume":"159","author":"Sherwood","year":"2010","journal-title":"Am. Heart J."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1111\/j.1553-2712.2010.00848.x","article-title":"Incremental benefit of 80-lead electrocardiogram body surface mapping over the 12-lead electrocardiogram in the detection of acute coronary syndromes in patients without ST-elevation myocardial infarction: Results from the Optimal Cardiovascular Diagnostic Evaluation Enabling Faster Treatment of Myocardial Infarction (OCCULT MI) trial","volume":"17","author":"Hoekstra","year":"2010","journal-title":"Acad. Emerg. Med."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1016\/S0735-1097(00)00581-7","article-title":"Predictive value of C-reactive protein and troponin T in patients with unstable angina: A comparative analysis. CAPTURE Investigators. Chimeric c7E3 AntiPlatelet Therapy in Unstable angina REfractory to standard treatment trial","volume":"35","author":"Heeschen","year":"2000","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1056\/NEJM200010193431602","article-title":"Markers of myocardial damage and inflammation in relation to long-term mortality in unstable coronary artery disease. FRISC Study Group. Fragmin during Instability in Coronary Artery Disease","volume":"343","author":"Lindahl","year":"2000","journal-title":"N. Engl. J. Med."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1016\/j.jacc.2006.05.056","article-title":"Troponin-T and N-terminal pro-B-type natriuretic peptide predict mortality benefit from coronary revascularization in acute coronary syndromes: A GUSTO-IV substudy","volume":"48","author":"James","year":"2006","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1056\/NEJMoa1415921","article-title":"Troponin and Cardiac Events in Stable Ischemic Heart Disease and Diabetes","volume":"373","author":"Everett","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.1016\/S0735-1097(02)01877-6","article-title":"Prognostic significance of elevated troponin I after percutaneous coronary intervention","volume":"39","author":"Cantor","year":"2002","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1111\/j.1553-2712.2011.01091.x","article-title":"Predictors of 30-day cardiovascular events in patients with prior percutaneous coronary intervention or coronary artery bypass grafting","volume":"18","author":"Esposito","year":"2011","journal-title":"Acad. Emerg. Med."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1016\/j.jcmg.2015.06.016","article-title":"hs-Troponin I Followed by CT Angiography Improves Acute Coronary Syndrome Risk Stratification Accuracy and Work-Up in Acute Chest Pain Patients: Results From ROMICAT II Trial","volume":"8","author":"Ferencik","year":"2015","journal-title":"JACC Cardiovasc. Imaging"},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S0735-1097(96)00447-0","article-title":"Troponin T identifies patients with unstable coronary artery disease who benefit from long-term antithrombotic protection. Fragmin in Unstable Coronary Artery Disease (FRISC) Study Group","volume":"29","author":"Lindahl","year":"1997","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1056\/NEJM199905273402103","article-title":"Benefit of abciximab in patients with refractory unstable angina in relation to serum troponin T levels. c7E3 Fab Antiplatelet Therapy in Unstable Refractory Angina (CAPTURE) Study Investigators","volume":"340","author":"Hamm","year":"1999","journal-title":"N. Engl. J. Med."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"2719","DOI":"10.1016\/j.jacc.2016.10.020","article-title":"High-Sensitivity Cardiac Troponin, Statin Therapy, and Risk of Coronary Heart Disease","volume":"68","author":"Ford","year":"2016","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1161\/CIRCRESAHA.115.307016","article-title":"Platelet-Mediated Thrombosis: From Bench to Bedside","volume":"118","author":"Gurbel","year":"2016","journal-title":"Circ. Res."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.cardiores.2003.11.036","article-title":"Role of platelets in coronary thrombosis and reperfusion of ischemic myocardium","volume":"61","author":"Gawaz","year":"2004","journal-title":"Cardiovasc. Res."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"33","DOI":"10.15420\/ecr.2016:34:2","article-title":"Antiplatelet Therapy in Acute Coronary Syndrome","volume":"12","author":"Layne","year":"2017","journal-title":"Eur. Cardiol."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1093\/oxfordjournals.jbchem.a021833","article-title":"Lipid peroxide overcomes the inability of platelet secretory phospholipase A2 to hydrolyze membrane phospholipids in rabbit platelets","volume":"122","author":"Akiba","year":"1997","journal-title":"J. Biochem."},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1007\/s10555-018-9755-8","article-title":"Bioactive lipid metabolism in platelet \u201cfirst responder\u201d and cancer biology","volume":"37","author":"Kopetz","year":"2018","journal-title":"Cancer Metastasis Rev."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"6405","DOI":"10.12659\/MSM.915111","article-title":"Association of Platelet Membrane Fatty Acid Composition with Markers of Oxidative Stress in Healthy Men","volume":"25","author":"Bikulciene","year":"2019","journal-title":"Med. Sci. Monit."},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"2862","DOI":"10.1161\/ATVBAHA.118.311804","article-title":"Genetically Determined Platelet Count and Risk of Cardiovascular Disease","volume":"38","author":"Gill","year":"2018","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_135","unstructured":"Rokkam, V.R., Killeen, R.B., and Kotagiri, R. (2025). Secondary Thrombocytosis, StatPearls."},{"key":"ref_136","first-page":"707438","article-title":"Reactive Thrombocytosis Associated with Acute Myocardial Infarction following STEMI with Percutaneous Coronary Intervention","volume":"2013","author":"Dumrongmongcolgul","year":"2013","journal-title":"Case Rep. Cardiol."},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"4214","DOI":"10.1182\/blood-2005-08-3526","article-title":"Molecular basis of the diagnosis and treatment of polycythemia vera and essential thrombocythemia","volume":"107","author":"Schafer","year":"2006","journal-title":"Blood"},{"key":"ref_138","doi-asserted-by":"crossref","unstructured":"Gruppo Italiano Studio Policitemia (1995). Polycythemia vera: The natural history of 1213 patients followed for 20 years. Ann. Intern. Med., 123, 656\u2013664.","DOI":"10.7326\/0003-4819-123-9-199511010-00003"},{"key":"ref_139","first-page":"403","article-title":"Myocardial infarction as a thrombotic complication of myeloproliferative disorders","volume":"16","author":"Petrou","year":"2016","journal-title":"Anatol. J. Cardiol."},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1056\/NEJMra035363","article-title":"Thrombocytosis","volume":"350","author":"Schafer","year":"2004","journal-title":"N. Engl. J. Med."},{"key":"ref_141","first-page":"1481","article-title":"Oxidative and nitrosative stress in myeloproliferative neoplasms: The impact on the AKT\/mTOR signaling pathway","volume":"23","author":"Djikic","year":"2018","journal-title":"JBUON"},{"key":"ref_142","first-page":"2860","article-title":"Increased oxidative stress in patients with essential thrombocythemia","volume":"17","author":"Durmus","year":"2013","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/S1658-3876(09)50039-8","article-title":"Studies on biomarkers for oxidative stress in patients with chronic myeloid leukemia","volume":"2","author":"Singh","year":"2009","journal-title":"Hematol. Oncol. Stem Cell Ther."},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"506","DOI":"10.7326\/0003-4819-82-4-506","article-title":"Platelet function in patients with high platelet counts","volume":"82","author":"Ginsburg","year":"1975","journal-title":"Ann. Intern. Med."},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1046\/j.1365-2141.2000.02030.x","article-title":"Increased platelet activation and abnormal membrane glycoprotein content and redistribution in myeloproliferative disorders","volume":"110","author":"Jensen","year":"2000","journal-title":"Br. J. Haematol."},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1182\/blood-2006-10-048298","article-title":"Increased adhesion to endothelial cells of erythrocytes from patients with polycythemia vera is mediated by laminin alpha5 chain and Lu\/BCAM","volume":"110","author":"Wautier","year":"2007","journal-title":"Blood"},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"315","DOI":"10.3324\/haematol.2010.031070","article-title":"Inflammation and thrombosis in essential thrombocythemia and polycythemia vera: Different role of C-reactive protein and pentraxin 3","volume":"96","author":"Barbui","year":"2011","journal-title":"Haematologica"},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1182\/blood-2009-02-206797","article-title":"Perspectives on thrombosis in essential thrombocythemia and polycythemia vera: Is leukocytosis a causative factor?","volume":"114","author":"Barbui","year":"2009","journal-title":"Blood"},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1016\/S0140-6736(78)92098-6","article-title":"Vascular occlusive episodes and venous haematocrit in primary proliferative polycythaemia","volume":"2","author":"Pearson","year":"1978","journal-title":"Lancet"},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1159\/000452791","article-title":"Urgent Coronary Artery Bypass Surgery in a Patient with Postinfarction Angina and Active Myelomonocytic Leukaemia","volume":"9","author":"Galea","year":"2016","journal-title":"Case Rep. Oncol."},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1002\/ajh.10155","article-title":"Acute myocardial infarction as the presenting symptom of acute myeloblastic leukemia with extreme hyperleukocytosis","volume":"71","author":"Cohen","year":"2002","journal-title":"Am. J. Hematol."},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.redox.2017.08.021","article-title":"Regulation of platelet activation and thrombus formation by reactive oxygen species","volume":"14","author":"Qiao","year":"2018","journal-title":"Redox Biol."},{"key":"ref_153","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1177\/095952871200300117","article-title":"General Views of the Composition of Animal Fluids","volume":"3","author":"Berzelius","year":"1812","journal-title":"Med. Chir. Trans."},{"key":"ref_154","first-page":"323","article-title":"Manual of Special Pathology and Therapeutics","volume":"15","author":"Lyons","year":"1855","journal-title":"Br. Foreign Med. Chir. Rev."},{"key":"ref_155","first-page":"465","article-title":"The Blood\u2014Its Chemistry, Physiology, and Pathology","volume":"12","author":"Williams","year":"1853","journal-title":"Br. Foreign Med. Chir. Rev."},{"key":"ref_156","first-page":"459","article-title":"On the Relative Powers of fresh and previously used Pepsine in the Digestion of Albumin","volume":"10","author":"Ransome","year":"1876","journal-title":"J. Anat. Physiol."},{"key":"ref_157","doi-asserted-by":"crossref","unstructured":"Caridi, G., Lugani, F., Angeletti, A., Campagnoli, M., Galliano, M., and Minchiotti, L. (2022). Variations in the Human Serum Albumin Gene: Molecular and Functional Aspects. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23031159"},{"key":"ref_158","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1038\/358209a0","article-title":"Atomic structure and chemistry of human serum albumin","volume":"358","author":"He","year":"1992","journal-title":"Nature"},{"key":"ref_159","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1172\/JCI100561","article-title":"A Formula and Nomogram for the Estimation of the Osmotic Pressure of Colloids from the Albumin and Total Protein Concentrations of Human Blood Sera","volume":"12","author":"Wells","year":"1933","journal-title":"J. Clin. Investig."},{"key":"ref_160","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1248\/bpb.25.695","article-title":"Practical aspects of the ligand-binding and enzymatic properties of human serum albumin","volume":"25","author":"Chuang","year":"2002","journal-title":"Biol. Pharm. Bull."},{"key":"ref_161","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/0002-8703(92)90667-K","article-title":"MDM. Serum albumin, coronary heart disease, and death","volume":"123","author":"Gilllum","year":"1992","journal-title":"Am. Heart J."},{"key":"ref_162","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/1047-2797(94)00105-3","article-title":"Low serum albumin. Association with diabetes mellitus and other cardiovascular risk factors but not with prevalent cardiovascular disease or carotid artery intima-media thickness. The Atherosclerosis Risk in Communities (ARIC) Study Investigators","volume":"5","author":"Folsom","year":"1995","journal-title":"Ann. Epidemiol."},{"key":"ref_163","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1111\/j.1523-1755.2005.00455.x","article-title":"C-reactive protein and albumin as predictors of all-cause and cardiovascular mortality in chronic kidney disease","volume":"68","author":"Menon","year":"2005","journal-title":"Kidney Int."},{"key":"ref_164","doi-asserted-by":"crossref","first-page":"22804","DOI":"10.1074\/jbc.M100575200","article-title":"Crystal structure analysis of warfarin binding to human serum albumin: Anatomy of drug site I","volume":"276","author":"Petitpas","year":"2001","journal-title":"J. Biol. Chem."},{"key":"ref_165","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1172\/JCI105968","article-title":"Interaction of the anticoagulant drug warfarin and its metabolites with human plasma albumin","volume":"48","year":"1969","journal-title":"J. Clin. Investig."},{"key":"ref_166","first-page":"642745","article-title":"A molecular dynamics approach to ligand-receptor interaction in the aspirin-human serum albumin complex","volume":"2012","author":"Alvarez","year":"2012","journal-title":"J. Biophys."},{"key":"ref_167","doi-asserted-by":"crossref","unstructured":"Marino-Ocampo, N., Rodriguez, D.F., Guerra Diaz, D., Zuniga-Nunez, D., Duarte, Y., Fuentealba, D., and Zacconi, F.C. (2023). Direct Oral FXa Inhibitors Binding to Human Serum Albumin: Spectroscopic, Calorimetric, and Computational Studies. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms24054900"},{"key":"ref_168","first-page":"CD001208","article-title":"Human albumin solution for resuscitation and volume expansion in critically ill patients","volume":"2011","author":"Roberts","year":"2011","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_169","doi-asserted-by":"crossref","first-page":"e00476","DOI":"10.14309\/ctg.0000000000000476","article-title":"Targeted Albumin Infusions Do Not Improve Systemic Inflammation or Cardiovascular Function in Decompensated Cirrhosis","volume":"13","author":"China","year":"2022","journal-title":"Clin. Transl. Gastroenterol."},{"key":"ref_170","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1161\/CIRCULATIONAHA.117.027666","article-title":"Myocardial Infarction with Nonobstructive Coronary Arteries (MINOCA): The Past, Present, and Future Management","volume":"135","author":"Pasupathy","year":"2017","journal-title":"Circulation"},{"key":"ref_171","first-page":"e17002","article-title":"Unraveling the Association Between Myocardial Infarction of Nonobstructive Coronary Arteries and Antiphospholipid Syndrome","volume":"13","author":"Ramjas","year":"2021","journal-title":"Cureus"},{"key":"ref_172","first-page":"621270","article-title":"Cardiovascular risk factors in the antiphospholipid syndrome","volume":"2014","author":"Levy","year":"2014","journal-title":"J. Immunol. Res."},{"key":"ref_173","doi-asserted-by":"crossref","unstructured":"Nocella, C., Bartimoccia, S., Cammisotto, V., D\u2019Amico, A., Pastori, D., Frati, G., Sciarretta, S., Rosa, P., Felici, C., and Riggio, O. (2021). Oxidative Stress in the Pathogenesis of Antiphospholipid Syndrome: Implications for the Atherothrombotic Process. Antioxidants, 10.","DOI":"10.3390\/antiox10111790"},{"key":"ref_174","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1007\/s12016-007-0008-9","article-title":"Systemic antiphospholipid syndrome and atherosclerosis","volume":"32","author":"Jara","year":"2007","journal-title":"Clin. Rev. Allergy Immunol."},{"key":"ref_175","doi-asserted-by":"crossref","unstructured":"van Holten, T.C., Waanders, L.F., de Groot, P.G., Vissers, J., Hoefer, I.E., Pasterkamp, G., Prins, M.W.J., and Roest, M. (2013). Circulating Biomarkers for Predicting Cardiovascular Disease Risk; a Systematic Review and Comprehensive Overview of Meta-Analyses. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0062080"},{"key":"ref_176","doi-asserted-by":"crossref","unstructured":"Neerman-Arbez, M., and Casini, A. (2018). Clinical Consequences and Molecular Bases of Low Fibrinogen Levels. Int. J. Mol. Sci., 19.","DOI":"10.3390\/ijms19010192"},{"key":"ref_177","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1179\/1351000213Y.0000000046","article-title":"Free radicals and endothelial dysfunction: Potential positive effects of TNF-\u03b1 inhibitors","volume":"18","author":"Murdaca","year":"2013","journal-title":"Redox Rep."},{"key":"ref_178","doi-asserted-by":"crossref","first-page":"284","DOI":"10.3324\/haematol.2019.236901","article-title":"Fibrin(ogen) in human disease: Both friend and foe","volume":"105","author":"Vilar","year":"2020","journal-title":"Haematologica"},{"key":"ref_179","doi-asserted-by":"crossref","unstructured":"Kryczka, K.E., Kruk, M., Demkow, M., and Lubiszewska, B. (2021). Fibrinogen and a Triad of Thrombosis, Inflammation, and the Renin-Angiotensin System in Premature Coronary Artery Disease in Women: A New Insight into Sex-Related Differences in the Pathogenesis of the Disease. Biomolecules, 11.","DOI":"10.3390\/biom11071036"},{"key":"ref_180","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/1047-2797(92)90095-8","article-title":"Update on fibrinogen as a cardiovascular risk factor","volume":"2","author":"Kannel","year":"1992","journal-title":"Ann. Epidemiol."},{"key":"ref_181","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1136\/hrt.69.4.338","article-title":"Fibrinogen in relation to personal history of prevalent hypertension, diabetes, stroke, intermittent claudication, coronary heart disease, and family history: The Scottish Heart Health Study","volume":"69","author":"Lee","year":"1993","journal-title":"Br. Heart J."},{"key":"ref_182","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1093\/aje\/kwm191","article-title":"Associations of plasma fibrinogen levels with established cardiovascular disease risk factors, inflammatory markers, and other characteristics: Individual participant meta-analysis of 154,211 adults in 31 prospective studies: The fibrinogen studies collaboration","volume":"166","author":"Kaptoge","year":"2007","journal-title":"Am. J. Epidemiol."},{"key":"ref_183","first-page":"16","article-title":"Candidate gene analysis of the fibrinogen phenotype reveals the importance of polygenic co-regulation","volume":"60\u201361","author":"Zandberg","year":"2017","journal-title":"Matrix Biol."},{"key":"ref_184","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1160\/TH08-11-0777","article-title":"Hypodysfibrinogenemia causing mild bleeding and thrombotic complications in a compound heterozygote of AalphaIVS4+1G>T mutation and Aalpha4841delC truncation (Aalpha(Perth))","volume":"101","author":"Jayo","year":"2009","journal-title":"Thromb. Haemost."},{"key":"ref_185","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1055\/s-0038-1661463","article-title":"Fibrinogen Milano II: A congenital dysfibrinogenaemia associated with juvenile arterial and venous thrombosis","volume":"55","author":"Haverkate","year":"1986","journal-title":"Thromb. Haemost."},{"key":"ref_186","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1373\/clinchem.2009.138347","article-title":"Gamma\u2019 fibrinogen: Evaluation of a new assay for study of associations with cardiovascular disease","volume":"56","author":"Lovely","year":"2010","journal-title":"Clin. Chem."},{"key":"ref_187","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1515\/cclm-2012-0005","article-title":"\u03b3\u2019 Fibrinogen as a novel marker of thrombotic disease","volume":"50","author":"Farrell","year":"2012","journal-title":"Clin. Chem. Lab. Med."},{"key":"ref_188","doi-asserted-by":"crossref","first-page":"3062","DOI":"10.1182\/blood.2019004781","article-title":"A Mendelian randomization of \u03b3\u2019 and total fibrinogen levels in relation to venous thromboembolism and ischemic stroke","volume":"136","author":"Maners","year":"2020","journal-title":"Blood"},{"key":"ref_189","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.thromres.2016.04.023","article-title":"Lack of association of plasma gamma prime (\u03b3\u2019) fibrinogen with incident cardiovascular disease","volume":"143","author":"Appiah","year":"2016","journal-title":"Thromb. Res."},{"key":"ref_190","doi-asserted-by":"crossref","unstructured":"Drizlionoka, K., Zari\u0146\u0161, J., Ozoli\u0146a, A., \u0145ikitina-Za\u0137e, L., and Mamaja, B. (2019). Polymorphism rs2066865 in the Fibrinogen Gamma Chain (FGG) Gene Increases Plasma Fibrinogen Concentration and Is Associated with an Increased Microvascular Thrombosis Rate. Medicina, 55.","DOI":"10.3390\/medicina55090563"},{"key":"ref_191","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1016\/j.thromres.2014.01.001","article-title":"Influence of the \u03b2-fibrinogen-455G\/A polymorphism on development of ischemic stroke and coronary heart disease","volume":"133","author":"Gu","year":"2014","journal-title":"Thromb. Res."},{"key":"ref_192","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s10072-013-1608-1","article-title":"Genetic polymorphism of \u03b2-fibrinogen gene-455G\/A can contribute to the risk of ischemic stroke","volume":"35","author":"Gu","year":"2014","journal-title":"Neurol. Sci."},{"key":"ref_193","first-page":"13195","article-title":"Plasma fibrinogen lever and risk of coronary heart disease among Chinese population: A systematic review and meta-analysis","volume":"8","author":"Song","year":"2015","journal-title":"Int. J. Clin. Exp. Med."},{"key":"ref_194","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1097\/CM9.0000000000000181","article-title":"Relationship between fibrinogen levels and cardiovascular events in patients receiving percutaneous coronary intervention: A large single-center study","volume":"132","author":"Jiang","year":"2019","journal-title":"Chin. Med. J."},{"key":"ref_195","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.jstrokecerebrovasdis.2018.09.007","article-title":"Associations of \u03b2-Fibrinogen Polymorphisms with the Risk of Ischemic Stroke: A Meta-analysis","volume":"28","author":"Luo","year":"2019","journal-title":"J. Stroke Cerebrovasc. Dis."},{"key":"ref_196","doi-asserted-by":"crossref","first-page":"e18204","DOI":"10.1097\/MD.0000000000018204","article-title":"Association of \u03b2-fibrinogen polymorphisms and venous thromboembolism risk: A PRISMA-compliant meta-analysis","volume":"98","author":"Li","year":"2019","journal-title":"Medicine"},{"key":"ref_197","doi-asserted-by":"crossref","first-page":"530","DOI":"10.2337\/diabetes.55.02.06.db05-1041","article-title":"Hemostatic markers of endothelial dysfunction and risk of incident type 2 diabetes: The Framingham Offspring Study","volume":"55","author":"Meigs","year":"2006","journal-title":"Diabetes"},{"key":"ref_198","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1161\/01.ATV.0000135995.39488.6c","article-title":"Interleukin-6, fibrin D-dimer, and coagulation factors VII and XIIa in prediction of coronary heart disease","volume":"24","author":"Lowe","year":"2004","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_199","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1161\/01.ATV.0000107402.79771.fc","article-title":"Genetic determinants of arterial thrombosis","volume":"24","author":"Voetsch","year":"2004","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_200","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1161\/01.CIR.99.8.999","article-title":"G20210A mutation in prothrombin gene and risk of myocardial infarction, stroke, and venous thrombosis in a large cohort of US men","volume":"99","author":"Ridker","year":"1999","journal-title":"Circulation"},{"key":"ref_201","doi-asserted-by":"crossref","first-page":"2186","DOI":"10.1182\/blood.V93.7.2186.407k28_2186_2190","article-title":"Synergistic effects of prothrombotic polymorphisms and atherogenic factors on the risk of myocardial infarction in young males","volume":"93","author":"Inbal","year":"1999","journal-title":"Blood"},{"key":"ref_202","doi-asserted-by":"crossref","first-page":"2604","DOI":"10.1182\/blood-2006-04-016527","article-title":"A prospective cohort study on the absolute incidence of venous thromboembolism and arterial cardiovascular disease in asymptomatic carriers of the prothrombin 20210A mutation","volume":"108","author":"Coppens","year":"2006","journal-title":"Blood"},{"key":"ref_203","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1016\/S0002-8703(03)00519-2","article-title":"Association between factor V Leiden, prothrombin G20210A, and methylenetetrahydrofolate reductase C677T mutations and events of the arterial circulatory system: A meta-analysis of published studies","volume":"146","author":"Kim","year":"2003","journal-title":"Am. Heart J."},{"key":"ref_204","doi-asserted-by":"crossref","first-page":"100048","DOI":"10.1016\/j.rpth.2023.100048","article-title":"Factor V Leiden but not the factor II 20210G>A mutation is a risk factor for premature coronary artery disease: A case-control study in Iran","volume":"7","author":"Agosti","year":"2023","journal-title":"Res. Pract. Thromb. Haemost."},{"key":"ref_205","doi-asserted-by":"crossref","first-page":"2817","DOI":"10.1182\/blood.V89.8.2817","article-title":"Factor V Leiden (resistance to activated protein C) increases the risk of myocardial infarction in young women","volume":"89","author":"Rosendaal","year":"1997","journal-title":"Blood"},{"key":"ref_206","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1161\/01.CIR.97.11.1037","article-title":"Interaction of coagulation defects and cardiovascular risk factors: Increased risk of myocardial infarction associated with factor V Leiden or prothrombin 20210A","volume":"97","author":"Doggen","year":"1998","journal-title":"Circulation"},{"key":"ref_207","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1097\/MBC.0b013e32832d6ce7","article-title":"Risk factors for clinical manifestations in carriers of Factor V Leiden and prothrombin gene mutations","volume":"21","author":"DeSancho","year":"2010","journal-title":"Blood Coagul. Fibrinolysis"},{"key":"ref_208","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1055\/s-0038-1657493","article-title":"Thrombosis in the young: Effect of atherosclerotic risk factors on the risk of myocardial infarction associated with prothrombotic factors","volume":"78","author":"Siscovick","year":"1997","journal-title":"Thromb. Haemost."},{"key":"ref_209","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1093\/annonc\/mdh146","article-title":"Factor V Leiden and G20210A prothrombin mutation and the risk of subclavian vein thrombosis in patients with breast cancer and a central venous catheter","volume":"15","author":"Mandala","year":"2004","journal-title":"Ann. Oncol."},{"key":"ref_210","doi-asserted-by":"crossref","first-page":"474","DOI":"10.20452\/pamw.2409","article-title":"Genetic risk factors of atherothrombosis","volume":"124","author":"Montagnana","year":"2014","journal-title":"Pol. Arch. Med. Wewn."},{"key":"ref_211","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jchf.2012.10.002","article-title":"Heart Failure","volume":"1","author":"Braunwald","year":"2013","journal-title":"JACC Heart Fail."},{"key":"ref_212","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1097\/00024382-199601000-00019","article-title":"Harrison\u2019s Principles of Internal Medicine","volume":"5","author":"Isselbacher","year":"1996","journal-title":"Shock"},{"key":"ref_213","doi-asserted-by":"crossref","first-page":"e287","DOI":"10.1161\/CIR.0000000000001024","article-title":"Diagnosis and Management of Patients with Myocardial Injury After Noncardiac Surgery: A Scientific Statement From the American Heart Association","volume":"144","author":"Ruetzler","year":"2021","journal-title":"Circulation"},{"key":"ref_214","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1373\/clinchem.2017.277186","article-title":"Clinical Laboratory Practice Recommendations for the Use of Cardiac Troponin in Acute Coronary Syndrome: Expert Opinion from the Academy of the American Association for Clinical Chemistry and the Task Force on Clinical Applications of Cardiac Bio-Markers of the International Federation of Clinical Chemistry and Laboratory Medicine","volume":"64","author":"Wu","year":"2018","journal-title":"Clin. Chem."},{"key":"ref_215","doi-asserted-by":"crossref","first-page":"4050","DOI":"10.1093\/eurheartj\/ehaa083","article-title":"High-sensitivity cardiac troponin assays for cardiovascular risk stratification in the general population","volume":"41","author":"Farmakis","year":"2020","journal-title":"Eur. Heart J."},{"key":"ref_216","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1080\/14737159.2017.1283219","article-title":"Using biomarkers to predict and to prevent cardiotoxicity of cancer therapy","volume":"17","author":"Cardinale","year":"2017","journal-title":"Expert. Rev. Mol. Diagn."},{"key":"ref_217","doi-asserted-by":"crossref","first-page":"4229","DOI":"10.1093\/eurheartj\/ehac244","article-title":"2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS)","volume":"43","author":"Lyon","year":"2022","journal-title":"Eur. Heart J."},{"key":"ref_218","doi-asserted-by":"crossref","first-page":"3599","DOI":"10.1093\/eurheartj\/ehab368","article-title":"2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure","volume":"42","author":"McDonagh","year":"2021","journal-title":"Eur. Heart J."},{"key":"ref_219","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1093\/eurheartj\/ehw128","article-title":"2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC)Developed with the special contribution of the Heart Failure Association (HFA) of the ESC","volume":"37","author":"Ponikowski","year":"2016","journal-title":"Eur. Heart J."},{"key":"ref_220","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1126\/science.2935937","article-title":"Atrial natriuretic peptide elevation in congestive heart failure in the human","volume":"231","author":"Burnett","year":"1986","journal-title":"Science"},{"key":"ref_221","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1373\/clinchem.2011.165720","article-title":"Emerging biomarkers in heart failure","volume":"58","author":"Januzzi","year":"2012","journal-title":"Clin. Chem."},{"key":"ref_222","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/S0002-9343(02)01185-3","article-title":"Heart failure after myocardial infarction: A review","volume":"113","author":"Hellermann","year":"2002","journal-title":"Am. J. Med."},{"key":"ref_223","doi-asserted-by":"crossref","first-page":"16900","DOI":"10.1074\/jbc.M201503200","article-title":"Processing of pro-atrial natriuretic peptide by corin in cardiac myocytes","volume":"277","author":"Wu","year":"2002","journal-title":"J. Biol. Chem."},{"key":"ref_224","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1172\/JCI100323","article-title":"Changes in Blood Volume in Patients with Edema of Renal Origin","volume":"9","author":"Waterfield","year":"1931","journal-title":"J. Clin. Investig."},{"key":"ref_225","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1172\/JCI101911","article-title":"Renal Plasma Flow and Sodium Reabsorption and Excretion in Congestive Heart Failure","volume":"27","author":"Mokotoff","year":"1948","journal-title":"J. Clin. Investig."},{"key":"ref_226","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1136\/hrt.23.1.66","article-title":"A Current Concept of the Regulation of Blood Volume","volume":"23","author":"Pearce","year":"1961","journal-title":"Br. Heart J."},{"key":"ref_227","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1172\/JCI102501","article-title":"Water diuresis produced during recumbency by the intravenous infusion of isotonic saline solution","volume":"30","author":"Strauss","year":"1951","journal-title":"J. Clin. Investig."},{"key":"ref_228","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1152\/jappl.1957.11.1.125","article-title":"Influence of Hydration, Venous Pooling and Adrenal Cortical Insufficiency on Postural Antidiuresis and Antisaluresis","volume":"11","author":"Taymor","year":"1957","journal-title":"J. Appl. Physiol."},{"key":"ref_229","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1139\/y59-011","article-title":"Mechanisms of the Renal Response to Plasma Volume Expansion","volume":"37","author":"Atkins","year":"1959","journal-title":"Can. J. Biochem. Physiol."},{"key":"ref_230","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1083\/jcb.23.1.151","article-title":"Specific Granules in Atrial Muscle Cells","volume":"23","author":"Jamieson","year":"1964","journal-title":"J. Cell Biol."},{"key":"ref_231","first-page":"99","article-title":"Electron microscopy of the atrium of the heart. I. Guinea pig","volume":"14","author":"Kisch","year":"1956","journal-title":"Exp. Med. Surg."},{"key":"ref_232","first-page":"549","article-title":"Degree of granularity of the atrial cardiocytes. Morphometric study in rats subjected to different types of water and sodium load","volume":"24","author":"Marie","year":"1976","journal-title":"Pathol. Biol."},{"key":"ref_233","first-page":"525","article-title":"Ultrastructual cytochemistry of atrial muscle cells. II. Characterization of the protein content of specific granules","volume":"30","author":"Huet","year":"1974","journal-title":"Lab. Investig."},{"key":"ref_234","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/0024-3205(81)90370-2","article-title":"A rapid and potent natriuretic response to intravenous injection of atrial myocardial extract in rats","volume":"28","author":"Borenstein","year":"1981","journal-title":"Life Sci."},{"key":"ref_235","doi-asserted-by":"crossref","first-page":"508","DOI":"10.3181\/00379727-161-40584","article-title":"Heart atria granularity effects of changes in water-electrolyte balance","volume":"161","year":"1979","journal-title":"Proc. Soc. Exp. Biol. Med."},{"key":"ref_236","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/0014-5793(83)80303-2","article-title":"Purification of three rat atrial natriuretic factors and their amino acid composition","volume":"164","author":"Thibault","year":"1983","journal-title":"FEBS Lett."},{"key":"ref_237","doi-asserted-by":"crossref","first-page":"I75","DOI":"10.1161\/01.HYP.5.2_Pt_2.I75","article-title":"Atrial natriuretic factor. Characterization and partial purification","volume":"5","author":"Thibault","year":"1983","journal-title":"Hypertension"},{"key":"ref_238","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/0006-291X(83)91675-3","article-title":"The amino acid sequence of an atrial peptide with potent diuretic and natriuretic properties","volume":"117","author":"Flynn","year":"1983","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_239","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1038\/312152a0","article-title":"Identification of rat gamma atrial natriuretic polypeptide and characterization of the cDNA encoding its precursor","volume":"312","author":"Kangawa","year":"1984","journal-title":"Nature"},{"key":"ref_240","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/0006-291X(84)90250-X","article-title":"Rat atrial natriuretic factor: Isolation, structure and biological activities of four major peptides","volume":"123","author":"Misono","year":"1984","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_241","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1038\/314264a0","article-title":"Atrial natriuretic factor\u2014A circulating hormone stimulated by volume loading","volume":"314","author":"Lang","year":"1985","journal-title":"Nature"},{"key":"ref_242","first-page":"S309","article-title":"Atriopeptins: Bioactive peptides derived from mammalian cardiac atria","volume":"2","author":"Currie","year":"1984","journal-title":"J. Hypertens. Suppl."},{"key":"ref_243","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1126\/science.6419347","article-title":"Purification and sequence analysis of bioactive atrial peptides (atriopeptins)","volume":"223","author":"Currie","year":"1984","journal-title":"Science"},{"key":"ref_244","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/0006-291X(84)91258-0","article-title":"Atriopeptins: A family of potent biologically active peptides derived from mammalian atria","volume":"120","author":"Geller","year":"1984","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_245","first-page":"2086","article-title":"Cloning, sequence analysis, and processing of the rat and human atrial natriuretic peptide precursors","volume":"45","author":"Lewicki","year":"1986","journal-title":"Fed. Proc."},{"key":"ref_246","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1038\/309724a0","article-title":"Cloning and sequence analysis of cDNA encoding a precursor for human atrial natriuretic polypeptide","volume":"309","author":"Oikawa","year":"1984","journal-title":"Nature"},{"key":"ref_247","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1373\/clinchem.2011.176990","article-title":"First identification of circulating prepro-A-type natriuretic peptide (preproANP) signal peptide fragments in humans: Initial assessment as cardiovascular biomarkers","volume":"58","author":"Pemberton","year":"2012","journal-title":"Clin. Chem."},{"key":"ref_248","doi-asserted-by":"crossref","first-page":"106","DOI":"10.3109\/07420529509064506","article-title":"Temporal (circadian) and functional relationship between atrial natriuretic peptides and blood pressure","volume":"12","author":"Sothern","year":"1995","journal-title":"Chronobiol. Int."},{"key":"ref_249","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1172\/JCI115146","article-title":"Brain natriuretic peptide as a novel cardiac hormone in humans. Evidence for an exquisite dual natriuretic peptide system, atrial natriuretic peptide and brain natriuretic peptide","volume":"87","author":"Mukoyama","year":"1991","journal-title":"J. Clin. Investig."},{"key":"ref_250","doi-asserted-by":"crossref","unstructured":"Potter, L.R., Yoder, A.R., Flora, D.R., Antos, L.K., and Dickey, D.M. (2009). Natriuretic peptides: Their structures, receptors, physiologic functions and therapeutic applications. Handbook of Experimental Pharmacology, Springer Nature.","DOI":"10.1007\/978-3-540-68964-5_15"},{"key":"ref_251","first-page":"F817","article-title":"Release of atrial natriuretic factor. Effects of repetitive stretch and temperature","volume":"251","author":"Bilder","year":"1986","journal-title":"Am. J. Physiol."},{"key":"ref_252","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1007\/s004180050295","article-title":"The endocrine heart and natriuretic peptides: Histochemistry, cell biology, and functional aspects of the renal urodilatin system","volume":"110","author":"Forssmann","year":"1998","journal-title":"Histochem. Cell Biol."},{"key":"ref_253","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/BF00870995","article-title":"The pharmacokinetics of alpha-human atrial natriuretic polypeptide in healthy subjects","volume":"31","author":"Nakao","year":"1986","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"ref_254","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1042\/bj2540531","article-title":"Hydrolysis of alpha-human atrial natriuretic peptide in vitro by human kidney membranes and purified endopeptidase-24.11. Evidence for a novel cleavage site","volume":"254","author":"Vanneste","year":"1988","journal-title":"Biochem. J."},{"key":"ref_255","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1016\/S0006-291X(87)80307-8","article-title":"Atrial natriuretic prohormone peptides 1\u201330, 31\u201367, and 79\u201398 vasodilate the aorta","volume":"148","author":"Vesely","year":"1987","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_256","doi-asserted-by":"crossref","first-page":"2033","DOI":"10.1210\/endo.136.5.7720651","article-title":"Kaliuretic peptide: The most potent inhibitor of Na(+)-K+ ATPase of the atrial natriuretic peptides","volume":"136","author":"Chiou","year":"1995","journal-title":"Endocrinology"},{"key":"ref_257","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1053\/meta.2000.18557","article-title":"Long-acting natriuretic peptide, vessel dilator, and kaliuretic peptide enhance the urinary excretion rate of beta2-microglobulin","volume":"49","author":"Vesely","year":"2000","journal-title":"Metabolism"},{"key":"ref_258","doi-asserted-by":"crossref","first-page":"230","DOI":"10.3181\/00379727-192-42990","article-title":"Increased release of the N-terminal and C-terminal portions of the prohormone of atrial natriuretic factor during immersion-induced central hypervolemia in normal humans","volume":"192","author":"Vesely","year":"1989","journal-title":"Proc. Soc. Exp. Biol. Med."},{"key":"ref_259","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1161\/01.CIR.90.3.1129","article-title":"Three peptides from the atrial natriuretic factor prohormone amino terminus lower blood pressure and produce diuresis, natriuresis, and\/or kaliuresis in humans","volume":"90","author":"Vesely","year":"1994","journal-title":"Circulation"},{"key":"ref_260","doi-asserted-by":"crossref","first-page":"3199","DOI":"10.2337\/db08-0649","article-title":"Atrial natriuretic peptide induces postprandial lipid oxidation in humans","volume":"57","author":"Birkenfeld","year":"2008","journal-title":"Diabetes"},{"key":"ref_261","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1056\/NEJM199807303390507","article-title":"Natriuretic peptides","volume":"339","author":"Levin","year":"1998","journal-title":"N. Engl. J. Med."},{"key":"ref_262","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1152\/jn.00057.2005","article-title":"C-type natriuretic peptide inhibits L-type Ca2+ current in rat magnocellular neurosecretory cells by activating the NPR-C receptor","volume":"94","author":"Rose","year":"2005","journal-title":"J. Neurophysiol."},{"key":"ref_263","doi-asserted-by":"crossref","first-page":"C1409","DOI":"10.1152\/ajpcell.1998.275.6.C1409","article-title":"G protein-dependent activation of smooth muscle eNOS via natriuretic peptide clearance receptor","volume":"275","author":"Murthy","year":"1998","journal-title":"Am. J. Physiol."},{"key":"ref_264","doi-asserted-by":"crossref","first-page":"4016","DOI":"10.1073\/pnas.071389098","article-title":"Dwarfism and early death in mice lacking C-type natriuretic peptide","volume":"98","author":"Chusho","year":"2001","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_265","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.ymgme.2007.06.014","article-title":"C-natriuretic peptide: An important regulator of cartilage","volume":"92","author":"Pejchalova","year":"2007","journal-title":"Mol. Genet. Metab."},{"key":"ref_266","doi-asserted-by":"crossref","first-page":"10079","DOI":"10.1073\/pnas.1632368100","article-title":"Four functionally distinct C-type natriuretic peptides found in fish reveal evolutionary history of the natriuretic peptide system","volume":"100","author":"Inoue","year":"2003","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_267","doi-asserted-by":"crossref","first-page":"170363","DOI":"10.1016\/j.peptides.2020.170363","article-title":"Circulating products of C-type natriuretic peptide and links with organ function in health and disease","volume":"132","author":"Prickett","year":"2020","journal-title":"Peptides"},{"key":"ref_268","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.1172\/JCI117182","article-title":"Molecular cloning of the complementary DNA and gene that encode mouse brain natriuretic peptide and generation of transgenic mice that overexpress the brain natriuretic peptide gene","volume":"93","author":"Ogawa","year":"1994","journal-title":"J. Clin. Investig."},{"key":"ref_269","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/0006-291X(91)91614-I","article-title":"Gene and precursor structures of human C-type natriuretic peptide","volume":"175","author":"Tawaragi","year":"1991","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_270","first-page":"H2919","article-title":"An autocrine system for C-type natriuretic peptide within rat carotid neointima during arterial repair","volume":"272","author":"Brown","year":"1997","journal-title":"Am. J. Physiol."},{"key":"ref_271","doi-asserted-by":"crossref","unstructured":"Jiao, Y., Yan, J., Jiao, F., Yang, H., Donahue, L.R., Li, X., A Roe, B., Stuart, J., and Gu, W. (2007). A single nucleotide mutation in Nppc is associated with a long bone abnormality in lbab mice. BMC Genet., 8.","DOI":"10.1186\/1471-2156-8-16"},{"key":"ref_272","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1161\/01.HYP.29.6.1296","article-title":"Shear stress augments expression of C-type natriuretic peptide and adrenomedullin","volume":"29","author":"Chun","year":"1997","journal-title":"Hypertension"},{"key":"ref_273","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1172\/JCI115933","article-title":"Endothelial production of C-type natriuretic peptide and its marked augmentation by transforming growth factor-beta. Possible existence of \u201cvascular natriuretic peptide system\u201d","volume":"90","author":"Suga","year":"1992","journal-title":"J. Clin. Investig."},{"key":"ref_274","first-page":"1428","article-title":"Bioactivity and metabolism of C-type natriuretic peptide in normal man","volume":"78","author":"Hunt","year":"1994","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_275","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1038\/nm971","article-title":"Overexpression of CNP in chondrocytes rescues achondroplasia through a MAPK-dependent pathway","volume":"10","author":"Yasoda","year":"2004","journal-title":"Nat. Med."},{"key":"ref_276","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1113\/jphysiol.2007.144253","article-title":"Natriuretic peptide C receptor signalling in the heart and vasculature","volume":"586","author":"Rose","year":"2008","journal-title":"J. Physiol."},{"key":"ref_277","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1093\/oxfordjournals.jbchem.a123539","article-title":"Bifunctional atrial natriuretic peptide receptor (type A) exists as a disulfide-linked tetramer in plasma membranes of bovine adrenal cortex","volume":"110","author":"Iwata","year":"1991","journal-title":"J. Biochem."},{"key":"ref_278","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1126\/science.1672777","article-title":"Selective activation of the B natriuretic peptide receptor by C-type natriuretic peptide (CNP)","volume":"252","author":"Koller","year":"1991","journal-title":"Science"},{"key":"ref_279","doi-asserted-by":"crossref","first-page":"14636","DOI":"10.1016\/S0021-9258(17)36672-3","article-title":"Protein kinase C-dependent desensitization of the atrial natriuretic peptide receptor is mediated by dephosphorylation","volume":"269","author":"Potter","year":"1994","journal-title":"J. Biol. Chem."},{"key":"ref_280","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.2741\/1613","article-title":"Domain analysis of human transmembrane guanylyl cyclase receptors: Implications for regulation","volume":"10","author":"Potter","year":"2005","journal-title":"Front. Biosci."},{"key":"ref_281","doi-asserted-by":"crossref","first-page":"26928","DOI":"10.1074\/jbc.M505648200","article-title":"ATP-independent activation of natriuretic peptide receptors","volume":"280","author":"Antos","year":"2005","journal-title":"J. Biol. Chem."},{"key":"ref_282","doi-asserted-by":"crossref","first-page":"6057","DOI":"10.1074\/jbc.R000033200","article-title":"Guanylyl cyclase-linked natriuretic peptide receptors: Structure and regulation","volume":"276","author":"Potter","year":"2001","journal-title":"J. Biol. Chem."},{"key":"ref_283","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1038\/378065a0","article-title":"Salt-resistant hypertension in mice lacking the guanylyl cyclase-A receptor for atrial natriuretic peptide","volume":"378","author":"Lopez","year":"1995","journal-title":"Nature"},{"key":"ref_284","doi-asserted-by":"crossref","first-page":"7142","DOI":"10.1073\/pnas.102650499","article-title":"Smooth muscle-selective deletion of guanylyl cyclase-A prevents the acute but not chronic effects of ANP on blood pressure","volume":"99","author":"Holtwick","year":"2002","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_285","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1152\/physiolgenomics.00083.2018","article-title":"Molecular and genetic aspects of guanylyl cyclase natriuretic peptide receptor-A in regulation of blood pressure and renal function","volume":"50","author":"Pandey","year":"2018","journal-title":"Physiol. Genom."},{"key":"ref_286","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1042\/CS20070109","article-title":"Atrial natriuretic peptide gene promoter polymorphism is associated with left ventricular hypertrophy in hypertension","volume":"114","author":"Xue","year":"2008","journal-title":"Clin. Sci."},{"key":"ref_287","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.jacc.2005.12.081","article-title":"Association of atrial natriuretic peptide and type a natriuretic peptide receptor gene polymorphisms with left ventricular mass in human essential hypertension","volume":"48","author":"Rubattu","year":"2006","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_288","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1038\/ng.328","article-title":"Association of common variants in NPPA and NPPB with circulating natriuretic peptides and blood pressure","volume":"41","author":"Larson","year":"2009","journal-title":"Nat. Genet."},{"key":"ref_289","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1172\/JCI17061","article-title":"Pressure-independent cardiac hypertrophy in mice with cardiomyocyte-restricted inactivation of the atrial natriuretic peptide receptor guanylyl cyclase-A","volume":"111","author":"Holtwick","year":"2003","journal-title":"J. Clin. Investig."},{"key":"ref_290","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1016\/0092-8674(89)90513-8","article-title":"The primary structure of a plasma membrane guanylate cyclase demonstrates diversity within this new receptor family","volume":"58","author":"Schulz","year":"1989","journal-title":"Cell"},{"key":"ref_291","doi-asserted-by":"crossref","first-page":"17300","DOI":"10.1073\/pnas.0407894101","article-title":"Critical roles of the guanylyl cyclase B receptor in endochondral ossification and development of female reproductive organs","volume":"101","author":"Tamura","year":"2004","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_292","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1086\/422013","article-title":"Mutations in the transmembrane natriuretic peptide receptor NPR-B impair skeletal growth and cause acromesomelic dysplasia, type Maroteaux","volume":"75","author":"Bartels","year":"2004","journal-title":"Am. J. Hum. Genet."},{"key":"ref_293","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1210\/jc.2005-1949","article-title":"Heterozygous mutations in natriuretic peptide receptor-B (NPR2) are associated with short stature","volume":"91","author":"Olney","year":"2006","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_294","doi-asserted-by":"crossref","first-page":"3518","DOI":"10.1210\/en.2007-0081","article-title":"Differential regulation of membrane guanylyl cyclases in congestive heart failure: Natriuretic peptide receptor (NPR)-B, Not NPR-A, is the predominant natriuretic peptide receptor in the failing heart","volume":"148","author":"Dickey","year":"2007","journal-title":"Endocrinology"},{"key":"ref_295","doi-asserted-by":"crossref","first-page":"4735","DOI":"10.1073\/pnas.0510019103","article-title":"Cardiac hypertrophy in transgenic rats expressing a dominant-negative mutant of the natriuretic peptide receptor B","volume":"103","author":"Langenickel","year":"2006","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_296","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1210\/endo.130.1.1309330","article-title":"Receptor selectivity of natriuretic peptide family, atrial natriuretic peptide, brain natriuretic peptide, and C-type natriuretic peptide","volume":"130","author":"Suga","year":"1992","journal-title":"Endocrinology"},{"key":"ref_297","doi-asserted-by":"crossref","first-page":"11650","DOI":"10.1016\/S0021-9258(18)67292-8","article-title":"Identification of multiple binding sites for atrial natriuretic factor by affinity cross-linking in cultured endothelial cells","volume":"261","author":"Leitman","year":"1986","journal-title":"J. Biol. Chem."},{"key":"ref_298","doi-asserted-by":"crossref","first-page":"7403","DOI":"10.1073\/pnas.96.13.7403","article-title":"The natriuretic peptide clearance receptor locally modulates the physiological effects of the natriuretic peptide system","volume":"96","author":"Matsukawa","year":"1999","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_299","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/S0006-291X(05)81312-9","article-title":"Atrial natriuretic factor in mammalian testis: Immunological detection in spermatozoa","volume":"180","author":"Pandey","year":"1991","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_300","doi-asserted-by":"crossref","first-page":"2277","DOI":"10.1210\/endo-126-5-2277","article-title":"Atrial natriuretic peptide is synthesized in the human thymus","volume":"126","author":"Vollmar","year":"1990","journal-title":"Endocrinology"},{"key":"ref_301","doi-asserted-by":"crossref","first-page":"13928","DOI":"10.1016\/S0021-9258(19)49658-0","article-title":"A new member of the natriuretic peptide family is present in the venom of the green mamba (Dendroaspis angusticeps)","volume":"267","author":"Schweitz","year":"1992","journal-title":"J. Biol. Chem."},{"key":"ref_302","first-page":"F832","article-title":"Urodilatin, a natriuretic factor from kidneys, can modify renal and cardiovascular function in men","volume":"259","author":"Saxenhofer","year":"1990","journal-title":"Am. J. Physiol."},{"key":"ref_303","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1152\/physrev.1990.70.3.665","article-title":"Diverse biological actions of atrial natriuretic peptide","volume":"70","author":"Brenner","year":"1990","journal-title":"Physiol. Rev."},{"key":"ref_304","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1126\/science.6326267","article-title":"Inhibition of aldosterone production by an atrial extract","volume":"224","author":"Atarashi","year":"1984","journal-title":"Science"},{"key":"ref_305","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1210\/endo-115-4-1636","article-title":"Specific receptor-mediated inhibition by synthetic atrial natriuretic factor of hormone-stimulated steroidogenesis in cultured bovine adrenal cells","volume":"115","author":"Racz","year":"1984","journal-title":"Endocrinology"},{"key":"ref_306","first-page":"F863","article-title":"Effects of synthetic atrial natriuretic factor on renal function and renin release","volume":"247","author":"Burnett","year":"1984","journal-title":"Am. J. Physiol."},{"key":"ref_307","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1016\/0006-291X(85)91918-7","article-title":"Atrial natriuretic factor inhibits vasopressin secretion from rat posterior pituitary","volume":"132","author":"Obana","year":"1985","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_308","doi-asserted-by":"crossref","first-page":"3444","DOI":"10.1073\/pnas.83.10.3444","article-title":"Effect of atrial natriuretic peptide on gonadotropin release in superfused rat pituitary cells","volume":"83","author":"Horvath","year":"1986","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_309","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.1111\/j.1742-4658.2011.08116.x","article-title":"Natriuretic peptide system: An overview of studies using genetically engineered animal models","volume":"278","author":"Kishimoto","year":"2011","journal-title":"FEBS J."},{"key":"ref_310","doi-asserted-by":"crossref","first-page":"13406","DOI":"10.1016\/S0021-9258(18)37719-6","article-title":"Identification and characterization of three distinct atrial natriuretic factor receptors. Evidence for tissue-specific heterogeneity of receptor subtypes in vascular smooth muscle, kidney tubular epithelium, and Leydig tumor cells by ligand binding, photoaffinity labeling, and tryptic proteolysis","volume":"263","author":"Pandey","year":"1988","journal-title":"J. Biol. Chem."},{"key":"ref_311","doi-asserted-by":"crossref","first-page":"3720","DOI":"10.1016\/S0021-9258(18)68984-7","article-title":"Atrial natriuretic peptide binding, cross-linking, and stimulation of cyclic GMP accumulation and particulate guanylate cyclase activity in cultured cells","volume":"263","author":"Leitman","year":"1988","journal-title":"J. Biol. Chem."},{"key":"ref_312","doi-asserted-by":"crossref","unstructured":"Tokudome, T., and Otani, K. (2022). Molecular Mechanism of Blood Pressure Regulation through the Atrial Natriuretic Peptide. Biology, 11.","DOI":"10.3390\/biology11091351"},{"key":"ref_313","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1124\/pr.115.010652","article-title":"Mechanisms of Vascular Smooth Muscle Contraction and the Basis for Pharmacologic Treatment of Smooth Muscle Disorders","volume":"68","author":"Brozovich","year":"2016","journal-title":"Pharmacol. Rev."},{"key":"ref_314","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1006\/bbrc.1994.1166","article-title":"Detection of C-type natriuretic peptide in human circulation and marked increase of plasma CNP level in septic shock patients","volume":"198","author":"Hama","year":"1994","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_315","doi-asserted-by":"crossref","first-page":"3038","DOI":"10.1210\/endo.133.6.8243333","article-title":"Cytokine-induced C-type natriuretic peptide (CNP) secretion from vascular endothelial cells\u2014Evidence for CNP as a novel autocrine\/paracrine regulator from endothelial cells","volume":"133","author":"Suga","year":"1993","journal-title":"Endocrinology"},{"key":"ref_316","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1210\/en.2013-1416","article-title":"Genetically altered mutant mouse models of guanylyl cyclase\/natriuretic peptide receptor-A exhibit the cardiac expression of proinflammatory mediators in a gene-dose-dependent manner","volume":"155","author":"Vellaichamy","year":"2014","journal-title":"Endocrinology"},{"key":"ref_317","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1152\/physiolgenomics.00147.2011","article-title":"Activation of IKK\/NF-\u03baB provokes renal inflammatory responses in guanylyl cyclase\/natriuretic peptide receptor-A gene-knockout mice","volume":"44","author":"Das","year":"2012","journal-title":"Physiol. Genom."},{"key":"ref_318","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.bbrc.2004.11.153","article-title":"Reduced cGMP signaling activates NF-kappaB in hypertrophied hearts of mice lacking natriuretic peptide receptor-A","volume":"327","author":"Vellaichamy","year":"2005","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_319","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1016\/j.bbrc.2008.01.017","article-title":"cGMP rescues mitochondrial dysfunction induced by glucose and insulin in myocytes","volume":"367","author":"Mitsuishi","year":"2008","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_320","doi-asserted-by":"crossref","first-page":"4033","DOI":"10.2337\/db15-0305","article-title":"Defective Natriuretic Peptide Receptor Signaling in Skeletal Muscle Links Obesity to Type 2 Diabetes","volume":"64","author":"Badin","year":"2015","journal-title":"Diabetes"},{"key":"ref_321","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.3892\/mmr.2015.3491","article-title":"MicroRNA-423-5p targets O-GlcNAc transferase to induce apoptosis in cardiomyocytes","volume":"12","author":"Luo","year":"2015","journal-title":"Mol. Med. Rep."},{"key":"ref_322","doi-asserted-by":"crossref","unstructured":"D\u2019Alessandra, Y., Chiesa, M., Carena, M.C., Beltrami, A.P., Rizzo, P., Buzzetti, M., Ricci, V., Ferrari, R., Fucili, A., and Livi, U. (2020). Differential Role of Circulating microRNAs to Track Progression and Pre-Symptomatic Stage of Chronic Heart Failure: A Pilot Study. Biomedicines, 8.","DOI":"10.3390\/biomedicines8120597"},{"key":"ref_323","doi-asserted-by":"crossref","unstructured":"Seronde, M.F., Vausort, M., Gayat, E., Goretti, E., Ng, L.L., Squire, I.B., Vodovar, N., Sadoune, M., Samuel, J.-L., and Thum, T. (2015). Circulating microRNAs and Outcome in Patients with Acute Heart Failure. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0142237"},{"key":"ref_324","doi-asserted-by":"crossref","first-page":"857","DOI":"10.3892\/mmr.2016.5344","article-title":"MicroRNA-423-5p mediates H2O2-induced apoptosis in cardiomyocytes through O-GlcNAc transferase","volume":"14","author":"Luo","year":"2016","journal-title":"Mol. Med. Rep."},{"key":"ref_325","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.1002\/ejhf.2700","article-title":"Diagnostic performance of microRNAs in the detection of heart failure with reduced or preserved ejection fraction: A systematic review and meta-analysis","volume":"24","author":"Parvan","year":"2022","journal-title":"Eur. J. Heart Fail."},{"key":"ref_326","doi-asserted-by":"crossref","unstructured":"Khurana, M.L., Mani, I., Kumar, P., Ramasamy, C., and Pandey, K.N. (2022). Ligand-Dependent Downregulation of Guanylyl Cyclase\/Natriuretic Peptide Receptor-A: Role of miR-128 and miR-195. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms232113381"},{"key":"ref_327","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/j.repc.2021.03.020","article-title":"Candidate microRNAs as prognostic biomarkers in heart failure: A systematic review","volume":"41","author":"Figueiredo","year":"2022","journal-title":"Rev. Port. Cardiol."},{"key":"ref_328","doi-asserted-by":"crossref","unstructured":"Pandey, K.N. (2022). Guanylyl cyclase\/natriuretic peptide receptor-A: Identification, molecular characterization, and physiological genomics. Front. Mol. Neurosci., 15.","DOI":"10.3389\/fnmol.2022.1076799"},{"key":"ref_329","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1084\/jem.52.4.561","article-title":"Serological Reactions in Pneumonia with a Non-Protein Somatic Fraction of Pneumococcus","volume":"52","author":"Tillett","year":"1930","journal-title":"J. Exp. Med."},{"key":"ref_330","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1084\/jem.73.2.173","article-title":"The Occurrence During Acute Infections of a Protein not Normally Present in the Blood: I. Distribution of the Reactive Protein in Patients\u2019 Sera and the Effect of Calcium on the Flocculation Reaction with C polysaccharide of Pneumococcus","volume":"73","author":"Abernethy","year":"1941","journal-title":"J. Exp. Med."},{"key":"ref_331","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1084\/jem.123.2.365","article-title":"The Liver as the Site of C-reactive Protein Formation","volume":"123","author":"Hurlimann","year":"1966","journal-title":"J. Exp. Med."},{"key":"ref_332","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1373\/clinchem.2008.119214","article-title":"C-reactive protein: Eighty years from discovery to emergence as a major risk marker for cardiovascular disease","volume":"55","author":"Ridker","year":"2009","journal-title":"Clin. Chem."},{"key":"ref_333","doi-asserted-by":"crossref","first-page":"4815","DOI":"10.4049\/jimmunol.156.12.4815","article-title":"Expression of C-reactive protein by alveolar macrophages","volume":"156","author":"Dong","year":"1996","journal-title":"J. Immunol."},{"key":"ref_334","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1016\/S0002-9440(10)62345-0","article-title":"Macrophage conditioned medium induces the expression of C-reactive protein in human aortic endothelial cells: Potential for paracrine\/autocrine effects","volume":"166","author":"Venugopal","year":"2005","journal-title":"Am. J. Pathol."},{"key":"ref_335","doi-asserted-by":"crossref","unstructured":"Sproston, N.R., and Ashworth, J.J. (2018). Role of C-Reactive Protein at Sites of Inflammation and Infection. Front. Immunol., 9.","DOI":"10.3389\/fimmu.2018.00754"},{"key":"ref_336","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/0014-5793(96)00528-5","article-title":"Two-dimensional crystallization of rabbit C-reactive protein on lipid monolayers","volume":"388","author":"Sui","year":"1996","journal-title":"FEBS Lett."},{"key":"ref_337","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1006\/bbrc.2001.5733","article-title":"Dissociation and subunit rearrangement of membrane-bound human C-reactive proteins","volume":"288","author":"Wang","year":"2001","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_338","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/S0021-9258(17)37943-7","article-title":"Primary structure of human C-reactive protein","volume":"254","author":"Oliveira","year":"1979","journal-title":"J. Biol. Chem."},{"key":"ref_339","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S0969-2126(99)80023-9","article-title":"The physiological structure of human C-reactive protein and its complex with phosphocholine","volume":"7","author":"Thompson","year":"1999","journal-title":"Structure"},{"key":"ref_340","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10875-007-9126-7","article-title":"Pentraxins in innate immunity: From C-reactive protein to the long pentraxin PTX3","volume":"28","author":"Mantovani","year":"2008","journal-title":"J. Clin. Immunol."},{"key":"ref_341","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/0022-1759(82)90300-3","article-title":"Isolation of human C-reactive protein and serum amyloid P component","volume":"50","author":"Pepys","year":"1982","journal-title":"J. Immunol. Methods"},{"key":"ref_342","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/0022-1759(78)90203-X","article-title":"C-reactive protein: Purification by affinity chromatography and physicochemical characterization","volume":"23","author":"Volanakis","year":"1978","journal-title":"J. Immunol. Methods"},{"key":"ref_343","doi-asserted-by":"crossref","first-page":"9840","DOI":"10.1021\/bi00451a044","article-title":"Elucidation of a protease-sensitive site involved in the binding of calcium to C-reactive protein","volume":"28","author":"Kinoshita","year":"1989","journal-title":"Biochemistry"},{"key":"ref_344","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1038\/nsb0496-346","article-title":"Three dimensional structure of human C-reactive protein","volume":"3","author":"Shrive","year":"1996","journal-title":"Nat. Struct. Biol."},{"key":"ref_345","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/S1471-4906(03)00030-9","article-title":"Recognition and clearance of apoptotic cells: A role for complement and pentraxins","volume":"24","author":"Nauta","year":"2003","journal-title":"Trends Immunol."},{"key":"ref_346","doi-asserted-by":"crossref","first-page":"612","DOI":"10.3181\/00379727-136-35323","article-title":"Specificity of C-reactive protein for choline phosphate residues of pneumococcal C-polysaccharide","volume":"136","author":"Volanakis","year":"1971","journal-title":"Proc. Soc. Exp. Biol. Med."},{"key":"ref_347","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S0161-5890(01)00042-6","article-title":"Human C-reactive protein: Expression, structure, and function","volume":"38","author":"Volanakis","year":"2001","journal-title":"Mol. Immunol."},{"key":"ref_348","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1016\/j.molimm.2004.09.028","article-title":"CRP after 2004","volume":"42","author":"Agrawal","year":"2005","journal-title":"Mol. Immunol."},{"key":"ref_349","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1093\/glycob\/cwg002","article-title":"Carbohydrate-binding properties of human neo-CRP and its relationship to phosphorylcholine-binding site","volume":"13","author":"Lee","year":"2003","journal-title":"Glycobiology"},{"key":"ref_350","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/0022-2836(90)90373-T","article-title":"Rotation function studies of human C-reactive protein","volume":"216","author":"Myles","year":"1990","journal-title":"J. Mol. Biol."},{"key":"ref_351","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/0009-8981(71)90225-7","article-title":"Identification of C-reactive protein by agarose gel electrophoresis of human serum or plasma","volume":"35","author":"Kindmark","year":"1971","journal-title":"Clin. Chim. Acta"},{"key":"ref_352","doi-asserted-by":"crossref","first-page":"3885","DOI":"10.4161\/cc.8.23.10068","article-title":"C-reactive protein: How conformational changes influence inflammatory properties","volume":"8","author":"Eisenhardt","year":"2009","journal-title":"Cell Cycle"},{"key":"ref_353","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1161\/01.CIR.0000029802.88087.5E","article-title":"A self-fulfilling prophecy: C-reactive protein attenuates nitric oxide production and inhibits angiogenesis","volume":"106","author":"Verma","year":"2002","journal-title":"Circulation"},{"key":"ref_354","doi-asserted-by":"crossref","first-page":"2094","DOI":"10.1161\/01.ATV.20.9.2094","article-title":"C-reactive protein in the arterial intima: Role of C-reactive protein receptor-dependent monocyte recruitment in atherogenesis","volume":"20","author":"Torzewski","year":"2000","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_355","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1146\/annurev.immunol.021908.132620","article-title":"Immune and inflammatory mechanisms of atherosclerosis","volume":"27","author":"Galkina","year":"2009","journal-title":"Annu. Rev. Immunol."},{"key":"ref_356","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1084\/jem.156.1.230","article-title":"Low density lipoprotein and very low density lipoprotein are selectively bound by aggregated C-reactive protein","volume":"156","author":"Soutar","year":"1982","journal-title":"J. Exp. Med."},{"key":"ref_357","doi-asserted-by":"crossref","first-page":"2348","DOI":"10.1161\/01.ATV.19.10.2348","article-title":"Complement and atherogenesis: Binding of CRP to degraded, nonoxidized LDL enhances complement activation","volume":"19","author":"Bhakdi","year":"1999","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_358","doi-asserted-by":"crossref","first-page":"13043","DOI":"10.1073\/pnas.192399699","article-title":"C-reactive protein binds to both oxidized LDL and apoptotic cells through recognition of a common ligand: Phosphorylcholine of oxidized phospholipids","volume":"99","author":"Chang","year":"2002","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_359","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1001\/jama.279.18.1477","article-title":"Association of fibrinogen, C-reactive protein, albumin, or leukocyte count with coronary heart disease: Meta-analyses of prospective studies","volume":"279","author":"Danesh","year":"1998","journal-title":"JAMA"},{"key":"ref_360","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1053\/euhj.1998.1309","article-title":"Risk factors for coronary heart disease and acute-phase proteins. A population-based study","volume":"20","author":"Danesh","year":"1999","journal-title":"Eur. Heart J."},{"key":"ref_361","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1001\/jama.297.6.611","article-title":"Development and validation of improved algorithms for the assessment of global cardiovascular risk in women: The Reynolds Risk Score","volume":"297","author":"Ridker","year":"2007","journal-title":"JAMA"},{"key":"ref_362","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1161\/01.CIR.0000053730.47739.3C","article-title":"Clinical application of C-reactive protein for cardiovascular disease detection and prevention","volume":"107","author":"Ridker","year":"2003","journal-title":"Circulation"},{"key":"ref_363","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1172\/JCI200318921","article-title":"C-reactive protein: A critical update","volume":"111","author":"Pepys","year":"2003","journal-title":"J. Clin. Investig."},{"key":"ref_364","doi-asserted-by":"crossref","first-page":"2292","DOI":"10.1161\/01.CIR.0000100688.17280.E6","article-title":"Rosuvastatin in the primary prevention of cardiovascular disease among patients with low levels of low-density lipoprotein cholesterol and elevated high-sensitivity C-reactive protein: Rationale and design of the JUPITER trial","volume":"108","author":"Ridker","year":"2003","journal-title":"Circulation"},{"key":"ref_365","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/1758-5996-4-28","article-title":"Metabolic syndrome and inflammatory biomarkers: A community-based cross-sectional study at the Framingham Heart Study","volume":"4","author":"Dallmeier","year":"2012","journal-title":"Diabetol. Metab. Syndr."},{"key":"ref_366","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1056\/NEJMoa042000","article-title":"Statin therapy, LDL cholesterol, C-reactive protein, and coronary artery disease","volume":"352","author":"Nissen","year":"2005","journal-title":"N. Engl. J. Med."},{"key":"ref_367","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1056\/NEJMoa042378","article-title":"C-reactive protein levels and outcomes after statin therapy","volume":"352","author":"Ridker","year":"2005","journal-title":"N. Engl. J. Med."},{"key":"ref_368","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1056\/NEJM200106283442601","article-title":"Measurement of C-reactive protein for the targeting of statin therapy in the primary prevention of acute coronary events","volume":"344","author":"Ridker","year":"2001","journal-title":"N. Engl. J. Med."},{"key":"ref_369","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1161\/CIRCULATIONAHA.106.643114","article-title":"C-reactive protein and prediction of coronary heart disease and global vascular events in the Prospective Study of Pravastatin in the Elderly at Risk (PROSPER)","volume":"115","author":"Sattar","year":"2007","journal-title":"Circulation"},{"key":"ref_370","doi-asserted-by":"crossref","first-page":"d6829","DOI":"10.1136\/bmj.d6829","article-title":"Prognostic effect size of cardiovascular biomarkers in datasets from observational studies versus randomised trials: Meta-epidemiology study","volume":"343","author":"Tzoulaki","year":"2011","journal-title":"BMJ"},{"key":"ref_371","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1161\/01.CIR.0000120707.98922.E3","article-title":"C-reactive protein modulates risk prediction based on the Framingham Score: Implications for future risk assessment: Results from a large cohort study in southern Germany","volume":"109","author":"Koenig","year":"2004","journal-title":"Circulation"},{"key":"ref_372","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1093\/ije\/dyn217","article-title":"Critical appraisal of CRP measurement for the prediction of coronary heart disease events: New data and systematic review of 31 prospective cohorts","volume":"38","author":"Shah","year":"2009","journal-title":"Int. J. Epidemiol."},{"key":"ref_373","doi-asserted-by":"crossref","first-page":"3078","DOI":"10.1161\/CIRCULATIONAHA.108.816694","article-title":"Predicting the 30-year risk of cardiovascular disease: The framingham heart study","volume":"119","author":"Pencina","year":"2009","journal-title":"Circulation"},{"key":"ref_374","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1161\/01.CIR.0000080289.72166.CF","article-title":"Plasma concentration of C-reactive protein and the calculated Framingham Coronary Heart Disease Risk Score","volume":"108","author":"Albert","year":"2003","journal-title":"Circulation"},{"key":"ref_375","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1161\/01.ATV.0000251993.20372.40","article-title":"Gamma glutamyl transferase and metabolic syndrome, cardiovascular disease, and mortality risk: The Framingham Heart Study","volume":"27","author":"Lee","year":"2007","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_376","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1161\/ATVBAHA.110.207977","article-title":"Cholesteryl ester transfer protein polymorphism (TaqIB) associates with risk in postinfarction patients with high C-reactive protein and high-density lipoprotein cholesterol levels","volume":"30","author":"Corsetti","year":"2010","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_377","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1161\/ATVBAHA.110.209544","article-title":"Increased coronary heart disease risk determined by high high-density lipoprotein cholesterol and C-reactive protein: Modulation by variation in the CETP gene","volume":"30","author":"Dullaart","year":"2010","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_378","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1161\/CIRCOUTCOMES.109.848473","article-title":"Number needed to treat with rosuvastatin to prevent first cardiovascular events and death among men and women with low low-density lipoprotein cholesterol and elevated high-sensitivity C-reactive protein: Justification for the use of statins in prevention: An intervention trial evaluating rosuvastatin (JUPITER)","volume":"2","author":"Ridker","year":"2009","journal-title":"Circ. Cardiovasc. Qual. Outcomes"},{"key":"ref_379","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1161\/CIRCOUTCOMES.110.938118","article-title":"Rosuvastatin for primary prevention among individuals with elevated high-sensitivity c-reactive protein and 5% to 10% and 10% to 20% 10-year risk. Implications of the Justification for Use of Statins in Prevention: An Intervention Trial Evaluating Rosuvastatin (JUPITER) trial for \u201cintermediate risk\u201d","volume":"3","author":"Ridker","year":"2010","journal-title":"Circ. Cardiovasc. Qual. Outcomes"},{"key":"ref_380","doi-asserted-by":"crossref","unstructured":"Heart Protection Study Collaborative Group (2009). Statin cost-effectiveness in the United States for people at different vascular risk levels. Circ. Cardiovasc. Qual. Outcomes, 2, 65\u201372.","DOI":"10.1161\/CIRCOUTCOMES.108.808469"},{"key":"ref_381","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1136\/hrt.2006.087932","article-title":"Accuracy and impact of risk assessment in the primary prevention of cardiovascular disease: A systematic review","volume":"92","author":"Brindle","year":"2006","journal-title":"Heart"},{"key":"ref_382","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/S0140-6736(12)60367-5","article-title":"The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: Meta-analysis of individual data from 27 randomised trials","volume":"380","author":"Mihaylova","year":"2012","journal-title":"Lancet"},{"key":"ref_383","doi-asserted-by":"crossref","first-page":"2575","DOI":"10.1161\/hs1101.098151","article-title":"Plasma concentration of C-reactive protein and risk of ischemic stroke and transient ischemic attack: The Framingham study","volume":"32","author":"Rost","year":"2001","journal-title":"Stroke"},{"key":"ref_384","doi-asserted-by":"crossref","first-page":"534","DOI":"10.4049\/jimmunol.116.2.534","article-title":"Regulation of antibody response in vitro. X. Biphasic effect of cyclic AMP on the secondary anti-hapten antibody response to anti-immunoglobulin and enhancing soluble factor","volume":"116","author":"Kishimoto","year":"1976","journal-title":"J. Immunol."},{"key":"ref_385","doi-asserted-by":"crossref","first-page":"7251","DOI":"10.1073\/pnas.84.20.7251","article-title":"Interferon beta 2\/B-cell stimulatory factor type 2 shares identity with monocyte-derived hepatocyte-stimulating factor and regulates the major acute phase protein response in liver cells","volume":"84","author":"Gauldie","year":"1987","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_386","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1126\/science.3136546","article-title":"Cloning and expression of the human interleukin-6 (BSF-2\/IFN beta 2) receptor","volume":"241","author":"Yamasaki","year":"1988","journal-title":"Science"},{"key":"ref_387","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1016\/0092-8674(90)90411-7","article-title":"Molecular cloning and expression of an IL-6 signal transducer, gp130","volume":"63","author":"Hibi","year":"1990","journal-title":"Cell"},{"key":"ref_388","doi-asserted-by":"crossref","first-page":"16","DOI":"10.3109\/08830185.2010.529976","article-title":"Pathogen recognition by the innate immune system","volume":"30","author":"Kumar","year":"2011","journal-title":"Int. Rev. Immunol."},{"key":"ref_389","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/0090-1229(89)90147-5","article-title":"Elevation of serum interleukin 6 prior to acute phase proteins on the inflammation by surgical operation","volume":"50","author":"Nishimoto","year":"1989","journal-title":"Clin. Immunol. Immunopathol."},{"key":"ref_390","doi-asserted-by":"crossref","first-page":"15959","DOI":"10.1073\/pnas.232432399","article-title":"Structure of the extracellular domains of the human interleukin-6 receptor alpha-chain","volume":"99","author":"Varghese","year":"2002","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_391","doi-asserted-by":"crossref","first-page":"2101","DOI":"10.1126\/science.1083901","article-title":"Hexameric structure and assembly of the interleukin-6\/IL-6 alpha-receptor\/gp130 complex","volume":"300","author":"Boulanger","year":"2003","journal-title":"Science"},{"key":"ref_392","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1006\/jmbi.1997.0933","article-title":"Solution structure of recombinant human interleukin-6","volume":"268","author":"Xu","year":"1997","journal-title":"J. Mol. Biol."},{"key":"ref_393","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1093\/emboj\/16.5.989","article-title":"1.9 \u00c5 crystal structure of interleukin 6: Implications for a novel mode of receptor dimerization and signaling","volume":"16","author":"Somers","year":"1997","journal-title":"EMBO J."},{"key":"ref_394","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1046\/j.1432-1327.1999.00511.x","article-title":"A role for the immunoglobulin-like domain of the human IL-6 receptor. Intracellular protein transport and shedding","volume":"263","author":"Vollmer","year":"1999","journal-title":"Eur. J. Biochem."},{"key":"ref_395","doi-asserted-by":"crossref","first-page":"6934","DOI":"10.1073\/pnas.87.18.6934","article-title":"Structural design and molecular evolution of a cytokine receptor superfamily","volume":"87","author":"Bazan","year":"1990","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_396","doi-asserted-by":"crossref","first-page":"a016295","DOI":"10.1101\/cshperspect.a016295","article-title":"IL-6 in inflammation, immunity, and disease","volume":"6","author":"Tanaka","year":"2014","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"ref_397","doi-asserted-by":"crossref","first-page":"4470","DOI":"10.4049\/jimmunol.172.7.4470","article-title":"CD14 is an acute-phase protein","volume":"172","author":"Bas","year":"2004","journal-title":"J. Immunol."},{"key":"ref_398","doi-asserted-by":"crossref","first-page":"E61","DOI":"10.1542\/peds.108.4.e61","article-title":"Reactive hyperemia and interleukin 6, interleukin 8, and tumor necrosis factor-alpha in the diagnosis of early-onset neonatal sepsis","volume":"108","author":"Martin","year":"2001","journal-title":"Pediatrics"},{"key":"ref_399","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1016\/0024-3205(92)90112-3","article-title":"Increase of plasma IL-6 concentration with age in healthy subjects","volume":"51","author":"Wei","year":"1992","journal-title":"Life Sci."},{"key":"ref_400","doi-asserted-by":"crossref","first-page":"2067","DOI":"10.1161\/01.CIR.0000034509.14906.AE","article-title":"Inflammatory cytokine concentrations are acutely increased by hyperglycemia in humans: Role of oxidative stress","volume":"106","author":"Esposito","year":"2002","journal-title":"Circulation"},{"key":"ref_401","doi-asserted-by":"crossref","unstructured":"Neal, B. (2008). Quantifying the importance of interleukin-6 for coronary heart disease. PLoS Med., 5.","DOI":"10.1371\/journal.pmed.0050084"},{"key":"ref_402","doi-asserted-by":"crossref","unstructured":"(2012). The Interleukin-6 Receptor Mendelian Randomisation Analysis (IL6R MR) Consortium. The interleukin-6 receptor as a target for prevention of coronary heart disease: A mendelian randomisation analysis. Lancet, 379, 1214\u20131224.","DOI":"10.1016\/S0140-6736(12)60110-X"},{"key":"ref_403","doi-asserted-by":"crossref","unstructured":"IL6R Genetics Consortium Emerging Risk Factors Collaboration (2012). Interleukin-6 receptor pathways in coronary heart disease: A collaborative meta-analysis of 82 studies. Lancet, 379, 1205\u20131213.","DOI":"10.1016\/S0140-6736(11)61931-4"},{"key":"ref_404","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1161\/01.CIR.94.5.874","article-title":"Elevated Levels of Interleukin-6 in Unstable Angina","volume":"94","author":"Biasucci","year":"1996","journal-title":"Circulation"},{"key":"ref_405","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1136\/heart.86.6.704","article-title":"Reciprocal increase of circulating interleukin-10 and interleukin-6 in patients with acute myocardial infarction","volume":"86","author":"Kotajima","year":"2001","journal-title":"Heart"},{"key":"ref_406","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1136\/hrt.78.3.273","article-title":"Relation of serum cytokine concentrations to cardiovascular risk factors and coronary heart disease","volume":"78","author":"Mendall","year":"1997","journal-title":"Heart"},{"key":"ref_407","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1111\/j.1538-7836.2007.02643.x","article-title":"Inter-relationships of interleukin-6, cardiovascular risk factors and the metabolic syndrome among older men","volume":"5","author":"Wannamethee","year":"2007","journal-title":"J. Thromb. Haemost."},{"key":"ref_408","doi-asserted-by":"crossref","first-page":"2312","DOI":"10.1046\/j.1538-7836.2003.00467.x","article-title":"Associations of plasma fibrinogen assays, C-reactive protein and interleukin-6 with previous myocardial infarction","volume":"1","author":"Lowe","year":"2003","journal-title":"J. Thromb. Haemost."},{"key":"ref_409","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1111\/joic.12103","article-title":"Interleukin-6, but not C-reactive protein, predicts the occurrence of cardiovascular events after drug-eluting stent for unstable angina","volume":"27","author":"Chen","year":"2014","journal-title":"J. Interv. Cardiol."},{"key":"ref_410","doi-asserted-by":"crossref","first-page":"R152","DOI":"10.1186\/cc11467","article-title":"Interleukin-6 is the strongest predictor of 30-day mortality in patients with cardiogenic shock due to myocardial infarction","volume":"16","author":"Becher","year":"2012","journal-title":"Crit. Care"},{"key":"ref_411","doi-asserted-by":"crossref","first-page":"301","DOI":"10.17305\/bjbms.2009.2784","article-title":"Correlation between interleukin 6 and interleukin 10 in acute myocardial infarction","volume":"9","year":"2009","journal-title":"Bosn. J. Basic Med. Sci."},{"key":"ref_412","doi-asserted-by":"crossref","unstructured":"Danesh, J., Kaptoge, S., Mann, A.G., Sarwar, N., Wood, A., Angleman, S.B., Wensley, F., Higgins, J.P.T., Lennon, L., and Eiriksdottir, G. (2008). Long-term interleukin-6 levels and subsequent risk of coronary heart disease: Two new prospective studies and a systematic review. PLoS Med., 5.","DOI":"10.1371\/journal.pmed.0050078"},{"key":"ref_413","doi-asserted-by":"crossref","first-page":"2317","DOI":"10.1161\/01.CIR.0000097109.90783.FC","article-title":"Inflammatory markers and onset of cardiovascular events: Results from the Health ABC study","volume":"108","author":"Cesari","year":"2003","journal-title":"Circulation"},{"key":"ref_414","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1002\/clc.4960241103","article-title":"Interleukin-6 and acute coronary syndrome","volume":"24","author":"Ikeda","year":"2001","journal-title":"Clin. Cardiol."},{"key":"ref_415","doi-asserted-by":"crossref","unstructured":"Georgakis, M.K., Malik, R., Richardson, T.G., Howson, J.M.M., Anderson, C.D., Burgess, S., Hovingh, G.K., Dichgans, M., and Gill, D. (2022). Associations of genetically predicted IL-6 signaling with cardiovascular disease risk across population subgroups. BMC Med., 20.","DOI":"10.1186\/s12916-022-02446-6"},{"key":"ref_416","first-page":"86","article-title":"Serum levels of interleukin-6 (Il-6), interleukin-18 (Il-18) and C-reactive protein (CRP) in patients with type-2 diabetes and acute coronary syndrome without ST-segment elevation","volume":"90","author":"Souza","year":"2008","journal-title":"Arq. Bras. Cardiol."},{"key":"ref_417","doi-asserted-by":"crossref","first-page":"2952","DOI":"10.1093\/eurheartj\/ehaa160","article-title":"Comparison of interleukin-6, C-reactive protein, and low-density lipoprotein cholesterol as biomarkers of residual risk in contemporary practice: Secondary analyses from the Cardiovascular Inflammation Reduction Trial","volume":"41","author":"Ridker","year":"2020","journal-title":"Eur. Heart J."},{"key":"ref_418","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1007\/s00392-018-1387-z","article-title":"Plasma interleukin 6 levels are associated with cardiac function after ST-elevation myocardial infarction","volume":"108","author":"Groot","year":"2019","journal-title":"Clin. Res. Cardiol."},{"key":"ref_419","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1016\/j.atherosclerosis.2008.07.031","article-title":"Association between IL-6 and the extent of coronary atherosclerosis in the veterans affairs diabetes trial (VADT)","volume":"203","author":"Saremi","year":"2009","journal-title":"Atherosclerosis"},{"key":"ref_420","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.1161\/01.CIR.99.16.2079","article-title":"Increasing Levels of Interleukin (IL)-1Ra and IL-6 During the First 2 Days of Hospitalization in Unstable Angina Are Associated with Increased Risk of In-Hospital Coronary Events","volume":"99","author":"Biasucci","year":"1999","journal-title":"Circulation"},{"key":"ref_421","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1002\/clc.4960251106","article-title":"Prognostic value of C-reactive protein, fibrinogen, interleukin-6, and macrophage colony stimulating factor in severe unstable angina","volume":"25","author":"Rallidis","year":"2002","journal-title":"Clin. Cardiol."},{"key":"ref_422","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/1475-2840-8-58","article-title":"Elevated plasma levels of TNF-alpha and Interleukin-6 in patients with diastolic dysfunction and glucose metabolism disorders","volume":"8","author":"Dinh","year":"2009","journal-title":"Cardiovasc. Diabetol."},{"key":"ref_423","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.amjcard.2006.01.045","article-title":"Interleukin-6 and the Risk of Future Cardiovascular Events in Patients with Angina Pectoris and\/or Healed Myocardial Infarction","volume":"98","author":"Fisman","year":"2006","journal-title":"Am. J. Cardiol."},{"key":"ref_424","doi-asserted-by":"crossref","first-page":"e001869","DOI":"10.1136\/openhrt-2021-001869","article-title":"High levels of interleukin-6 are associated with final infarct size and adverse clinical events in patients with STEMI","volume":"8","author":"Shetelig","year":"2021","journal-title":"Open Heart"},{"key":"ref_425","doi-asserted-by":"crossref","first-page":"106806","DOI":"10.1016\/j.vph.2020.106806","article-title":"Interleukin-6 level is a powerful predictor of long-term cardiovascular mortality in patients with acute coronary syndrome","volume":"135","author":"Gager","year":"2020","journal-title":"Vasc. Pharmacol."},{"key":"ref_426","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1253\/circj.70.426","article-title":"Close association of regional interleukin-6 levels in the infarct-related culprit coronary artery with restenosis in acute myocardial infarction","volume":"70","author":"Funayama","year":"2006","journal-title":"Circ. J."},{"key":"ref_427","doi-asserted-by":"crossref","unstructured":"Orrem, H.L., Nilsson, P.H., Pischke, S.E., Kleveland, O., Yndestad, A., Ekholt, K., Dam\u00e5s, J.K., Espevik, T., Bendz, B., and Halvorsen, B. (2018). IL-6 Receptor Inhibition by Tocilizumab Attenuated Expression of C5a Receptor 1 and 2 in Non-ST-Elevation Myocardial Infarction. Front. Immunol., 9.","DOI":"10.3389\/fimmu.2018.02035"},{"key":"ref_428","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1016\/j.jacc.2021.02.049","article-title":"Randomized Trial of Interleukin-6 Receptor Inhibition in Patients with Acute ST-Segment Elevation Myocardial Infarction","volume":"77","author":"Broch","year":"2021","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_429","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1161\/CIRCULATIONAHA.120.053318","article-title":"Treatment Effects of Interleukin-6 Receptor Antibodies for Modulating the Systemic Inflammatory Response After Out-of-Hospital Cardiac Arrest (The IMICA Trial): A Double-Blinded, Placebo-Controlled, Single-Center, Randomized, Clinical Trial","volume":"143","author":"Meyer","year":"2021","journal-title":"Circulation"},{"key":"ref_430","first-page":"65","article-title":"Is there a link between TNF gene expression and cognitive deficits in depression?","volume":"64","author":"Szemraj","year":"2017","journal-title":"Acta Biochim. Pol."},{"key":"ref_431","first-page":"389","article-title":"Journal of the National Cancer Institute, Vol. 29, 1962: Action of bacterial polysaccharide on tumors. II. Damage of sarcoma 37 by serum of mice treated with Serratia marcescens polysaccharide, and induced tolerance","volume":"46","author":"Achinstein","year":"1988","journal-title":"Nutr. Rev."},{"key":"ref_432","doi-asserted-by":"crossref","first-page":"3666","DOI":"10.1073\/pnas.72.9.3666","article-title":"An endotoxin-induced serum factor that causes necrosis of tumors","volume":"72","author":"Carswell","year":"1975","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_433","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1182\/blood-2011-04-325225","article-title":"Historical perspectives on tumor necrosis factor and its superfamily: 25 years later, a golden journey","volume":"119","author":"Aggarwal","year":"2012","journal-title":"Blood"},{"key":"ref_434","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1038\/312724a0","article-title":"Human tumour necrosis factor: Precursor structure, expression and homology to lymphotoxin","volume":"312","author":"Pennica","year":"1984","journal-title":"Nature"},{"key":"ref_435","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1126\/science.3856324","article-title":"Molecular cloning of the complementary DNA for human tumor necrosis factor","volume":"228","author":"Wang","year":"1985","journal-title":"Science"},{"key":"ref_436","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1038\/316552a0","article-title":"Identity of tumour necrosis factor and the macrophage-secreted factor cachectin","volume":"316","author":"Beutler","year":"1985","journal-title":"Nature"},{"key":"ref_437","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1126\/science.3764421","article-title":"Shock and tissue injury induced by recombinant human cachectin","volume":"234","author":"Tracey","year":"1986","journal-title":"Science"},{"key":"ref_438","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1126\/science.3895437","article-title":"Passive immunization against cachectin\/tumor necrosis factor protects mice from lethal effect of endotoxin","volume":"229","author":"Beutler","year":"1985","journal-title":"Science"},{"key":"ref_439","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1128\/iai.32.3.1058-1066.1981","article-title":"Possible importance of macrophage-derived mediators in acute malaria","volume":"32","author":"Clark","year":"1981","journal-title":"Infect. Immun."},{"key":"ref_440","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1007\/BF01716573","article-title":"Suggested importance of monokines in pathophysiology of endotoxin shock and malaria","volume":"60","author":"Clark","year":"1982","journal-title":"Klin. Wochenschr."},{"key":"ref_441","doi-asserted-by":"crossref","first-page":"2345","DOI":"10.1016\/S0021-9258(18)89560-6","article-title":"Human tumor necrosis factor. Production, purification, and characterization","volume":"260","author":"Aggarwal","year":"1985","journal-title":"J. Biol. Chem."},{"key":"ref_442","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/S0083-6729(04)67023-3","article-title":"Regulation of TRAIL-induced apoptosis by ectopic expression of antiapoptotic factors","volume":"67","author":"Aggarwal","year":"2004","journal-title":"Vitam. Horm."},{"key":"ref_443","doi-asserted-by":"crossref","first-page":"7077","DOI":"10.1128\/IAI.73.11.7077-7088.2005","article-title":"Role of lymphotoxin in experimental models of infectious diseases: Potential benefits and risks of a therapeutic inhibition of the lymphotoxin-beta receptor pathway","volume":"73","author":"Spahn","year":"2005","journal-title":"Infect. Immun."},{"key":"ref_444","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1073\/pnas.61.4.1250","article-title":"Lymphocyte in vitro cytotoxicity: Characterization of human lymphotoxin","volume":"61","author":"Kolb","year":"1968","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_445","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1084\/jem.128.6.1267","article-title":"Cytotoxicity mediated by soluble antigen and lymphocytes in delayed hypersensitivity. 3. Analysis of mechanism","volume":"128","author":"Ruddle","year":"1968","journal-title":"J. Exp. Med."},{"key":"ref_446","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1615\/CritRevEukarGeneExpr.v20.i2.10","article-title":"Tumor necrosis factor-\u03b1 signaling in macrophages","volume":"20","author":"Parameswaran","year":"2010","journal-title":"Crit. Rev. Eukaryot. Gene Expr."},{"key":"ref_447","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/0092-8674(88)90486-2","article-title":"A novel form of TNF\/cachectin is a cell surface cytotoxic transmembrane protein: Ramifications for the complex physiology of TNF","volume":"53","author":"Kriegler","year":"1988","journal-title":"Cell"},{"key":"ref_448","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1038\/385729a0","article-title":"A metalloproteinase disintegrin that releases tumour-necrosis factor-alpha from cells","volume":"385","author":"Black","year":"1997","journal-title":"Nature"},{"key":"ref_449","doi-asserted-by":"crossref","first-page":"3938","DOI":"10.1158\/0008-5472.CAN-13-0002","article-title":"Membrane versus soluble isoforms of TNF-\u03b1 exert opposing effects on tumor growth and survival of tumor-associated myeloid cells","volume":"73","author":"Ardestani","year":"2013","journal-title":"Cancer Res."},{"key":"ref_450","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/1750-2187-8-12","article-title":"Membrane TNF-alpha-activated programmed necrosis is mediated by Ceramide-induced reactive oxygen species","volume":"8","author":"Ardestani","year":"2013","journal-title":"J. Mol. Signal."},{"key":"ref_451","doi-asserted-by":"crossref","first-page":"8093","DOI":"10.1073\/pnas.94.15.8093","article-title":"Characterization of tumor necrosis factor-deficient mice","volume":"94","author":"Marino","year":"1997","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_452","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1038\/nrrheum.2015.40","article-title":"Atherosclerosis in rheumatoid arthritis: Is it all about inflammation?","volume":"11","author":"Skeoch","year":"2015","journal-title":"Nat. Rev. Rheumatol."},{"key":"ref_453","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1038\/nm.3925","article-title":"Tumor necrosis factor-\u03b1 confers cardioprotection through ectopic expression of keratins K8 and K18","volume":"21","author":"Papathanasiou","year":"2015","journal-title":"Nat. Med."},{"key":"ref_454","doi-asserted-by":"crossref","first-page":"2692","DOI":"10.1172\/JCI29134","article-title":"TNF provokes cardiomyocyte apoptosis and cardiac remodeling through activation of multiple cell death pathways","volume":"117","author":"Haudek","year":"2007","journal-title":"J. Clin. Investig."},{"key":"ref_455","doi-asserted-by":"crossref","first-page":"1985","DOI":"10.1016\/j.bpj.2008.11.036","article-title":"Impedance-based monitoring of ongoing cardiomyocyte death induced by tumor necrosis factor-alpha","volume":"96","author":"Qiu","year":"2009","journal-title":"Biophys. J."},{"key":"ref_456","doi-asserted-by":"crossref","first-page":"7","DOI":"10.2174\/1875397300903010007","article-title":"A Cell-based beta-Lactamase Reporter Gene Assay for the CREB Signaling Pathway","volume":"3","author":"Xia","year":"2009","journal-title":"Curr. Chem. Genom."},{"key":"ref_457","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.ahj.2008.02.025","article-title":"Tumor necrosis factor-alpha antagonist use and heart failure in elderly patients with rheumatoid arthritis","volume":"156","author":"Setoguchi","year":"2008","journal-title":"Am. Heart J."},{"key":"ref_458","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1002\/art.22447","article-title":"Effects of tumor necrosis factor blockade on cardiovascular risk factors in psoriatic arthritis: A double-blind, placebo-controlled study","volume":"56","author":"Sattar","year":"2007","journal-title":"Arthritis Rheum."},{"key":"ref_459","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1136\/ard.2004.023119","article-title":"Influence of anti-tumour necrosis factor therapy on cardiovascular risk factors in patients with active rheumatoid arthritis","volume":"64","author":"Popa","year":"2005","journal-title":"Ann. Rheum. Dis."},{"key":"ref_460","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1002\/acr.20371","article-title":"Systematic review and meta-analysis: Anti-tumor necrosis factor \u03b1 therapy and cardiovascular events in rheumatoid arthritis","volume":"63","author":"Barnabe","year":"2011","journal-title":"Arthritis Care Res."},{"key":"ref_461","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1136\/annrheumdis-2014-206624","article-title":"The effects of tumour necrosis factor inhibitors, methotrexate, non-steroidal anti-inflammatory drugs and corticosteroids on cardiovascular events in rheumatoid arthritis, psoriasis and psoriatic arthritis: A systematic review and meta-analysis","volume":"74","author":"Roubille","year":"2015","journal-title":"Ann. Rheum. Dis."},{"key":"ref_462","first-page":"342649","article-title":"Serum levels of anticyclic citrullinated peptide antibodies, interleukin-6, tumor necrosis factor-\u03b1, and C-reactive protein are associated with increased carotid intima-media thickness: A cross-sectional analysis of a cohort of rheumatoid arthritis patients without cardiovascular risk factors","volume":"2015","year":"2015","journal-title":"Biomed. Res. Int."},{"key":"ref_463","doi-asserted-by":"crossref","first-page":"49","DOI":"10.7812\/TPP\/13-092","article-title":"Relationship between tumor necrosis factor-\u03b1 inhibitors and cardiovascular disease in psoriasis: A review","volume":"18","author":"Nguyen","year":"2014","journal-title":"Perm. J."},{"key":"ref_464","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1194\/jlr.R600021-JLR200","article-title":"The role of TNF-alpha in chronic inflammatory conditions, intermediary metabolism, and cardiovascular risk","volume":"48","author":"Popa","year":"2007","journal-title":"J. Lipid Res."},{"key":"ref_465","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/j.ihj.2014.08.006","article-title":"Prevalence of nonalcoholic fatty liver disease (NAFLD) in patients of cardiovascular diseases and its association with hs-CRP and TNF-\u03b1","volume":"66","author":"Ajmal","year":"2014","journal-title":"Indian Heart J."},{"key":"ref_466","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1046\/j.1365-2796.2000.00705.x","article-title":"Tumour necrosis factor-alpha plasma level in patients with type 1 diabetes mellitus and its association with glycaemic control and cardiovascular risk factors","volume":"248","author":"Lechleitner","year":"2000","journal-title":"J. Intern. Med."},{"key":"ref_467","doi-asserted-by":"crossref","first-page":"419","DOI":"10.5551\/jat.No968","article-title":"Association of genetic variation in serum amyloid-A with cardiovascular disease and interactions with IL6, IL1RN, IL1beta and TNF genes in the Cardiovascular Health Study","volume":"16","author":"Carty","year":"2009","journal-title":"J. Atheroscler. Thromb."},{"key":"ref_468","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1186\/1742-2094-9-235","article-title":"Polymorphism of tumor necrosis factor alpha (TNF-alpha) gene promoter, circulating TNF-alpha level, and cardiovascular risk factor for ischemic stroke","volume":"9","author":"Cui","year":"2012","journal-title":"J. Neuroinflamm."},{"key":"ref_469","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.33963\/KP.14989","article-title":"Leptin, adiponectin, tumor necrosis factor \u03b1, and irisin concentrations as factors linking obesity with the risk of atrial fibrillation among inpatients with cardiovascular diseases","volume":"77","author":"Anaszewicz","year":"2019","journal-title":"Kardiol. Pol."},{"key":"ref_470","doi-asserted-by":"crossref","unstructured":"Pereira-da-Silva, T., Napole\u00e3o, P., Costa, M.C., Gabriel, A.F., Selas, M., Silva, F., Enguita, F.J., Ferreira, R.C., and Carmo, M.M. (2021). Association between miR-146a and Tumor Necrosis Factor Alpha (TNF-\u03b1) in Stable Coronary Artery Disease. Medicina, 57.","DOI":"10.3390\/medicina57060575"},{"key":"ref_471","doi-asserted-by":"crossref","first-page":"e008299","DOI":"10.1161\/JAHA.117.008299","article-title":"10-Year Associations Between Tumor Necrosis Factor Receptors 1 and 2 and Cardiovascular Events in Patients with Stable Coronary Heart Disease: A CLARICOR (Effect of Clarithromycin on Mortality and Morbidity in Patients with Ischemic Heart Disease) Trial Substudy","volume":"7","author":"Carlsson","year":"2018","journal-title":"J. Am. Heart Assoc."},{"key":"ref_472","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.atherosclerosis.2013.11.069","article-title":"Leptin and coronary heart disease: A systematic review and meta-analysis","volume":"233","author":"Chai","year":"2014","journal-title":"Atherosclerosis"},{"key":"ref_473","doi-asserted-by":"crossref","first-page":"4049","DOI":"10.3390\/ijerph110404049","article-title":"Relationship between obesity, adipocytokines and inflammatory markers in type 2 diabetes: Relevance for cardiovascular risk prevention","volume":"11","author":"Rajkovic","year":"2014","journal-title":"Int. J. Environ. Res. Public Health"},{"key":"ref_474","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1038\/382589a0","article-title":"Human leptin characterization","volume":"382","author":"Cohen","year":"1996","journal-title":"Nature"},{"key":"ref_475","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1038\/nm1195-1155","article-title":"Leptin levels in human and rodent: Measurement of plasma leptin and ob RNA in obese and weight-reduced subjects","volume":"1","author":"Maffei","year":"1995","journal-title":"Nat. Med."},{"key":"ref_476","first-page":"41","article-title":"Different associations of adipokines in lean and healthy adults","volume":"46","author":"Ebert","year":"2014","journal-title":"Horm. Metab. Res."},{"key":"ref_477","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1038\/ijo.2009.204","article-title":"Adipocytokines and the risk of coronary heart disease in healthy middle aged men: The PRIME Study","volume":"34","author":"Luc","year":"2010","journal-title":"Int. J. Obes."},{"key":"ref_478","doi-asserted-by":"crossref","first-page":"3238","DOI":"10.1161\/CIRCULATIONAHA.107.741645","article-title":"Leptin and Cardiovascular Disease","volume":"117","author":"Koh","year":"2008","journal-title":"Circulation"},{"key":"ref_479","doi-asserted-by":"crossref","first-page":"4823","DOI":"10.1210\/jc.2003-030214","article-title":"Serum Adiponectin Levels Are Inversely Associated with Overall and Central Fat Distribution but Are Not Directly Regulated by Acute Fasting or Leptin Administration in Humans: Cross-Sectional and Interventional Studies","volume":"88","author":"Gavrila","year":"2003","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_480","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.2337\/diabetes.52.7.1779","article-title":"Adiponectin Expression From Human Adipose Tissue: Relation to Obesity, Insulin Resistance, and Tumor Necrosis Factor-\u03b1 Expression","volume":"52","author":"Kern","year":"2003","journal-title":"Diabetes"},{"key":"ref_481","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1001\/jama.2009.976","article-title":"Adiponectin Levels and Risk of Type 2 Diabetes","volume":"302","author":"Li","year":"2009","journal-title":"JAMA"},{"key":"ref_482","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1055\/s-2007-958630","article-title":"Adiponectin and Cardiovascular Mortality: Evidence for \u201cReverse Epidemiology\u201d","volume":"39","author":"Rathmann","year":"2007","journal-title":"Horm. Metab. Res."},{"key":"ref_483","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1007\/s00125-011-2067-y","article-title":"Insulin resistance influences the association of adiponectin levels with diabetes incidence in two population-based cohorts: The Cooperative Health Research in the Region of Augsburg (KORA) S4\/F4 study and the Framingham Offspring Study","volume":"54","author":"Hivert","year":"2011","journal-title":"Diabetologia"},{"key":"ref_484","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1210\/jc.2009-2286","article-title":"Hypoadiponectinemia\u2014Cause or Consequence of Human \u201cInsulin Resistance\u201d?","volume":"95","author":"Cook","year":"2010","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_485","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1111\/j.1464-5491.2010.03043.x","article-title":"Associations between leptin and the leptin\/adiponectin ratio and incident Type 2 diabetes in middle-aged men and women: Results from the MONICA\/KORA Augsburg Study 1984\u20132002","volume":"27","author":"Thorand","year":"2010","journal-title":"Diabet. Med."},{"key":"ref_486","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/j.metabol.2009.08.017","article-title":"The association of tumor necrosis factor alpha receptor 2 and tumor necrosis factor alpha with insulin resistance and the influence of adipose tissue biomarkers in humans","volume":"59","author":"Hivert","year":"2010","journal-title":"Metabolism"},{"key":"ref_487","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1111\/j.1476-5381.2011.01395.x","article-title":"Adiponectin and cardiovascular health: An update","volume":"165","author":"Hui","year":"2012","journal-title":"Br. J. Pharmacol."},{"key":"ref_488","doi-asserted-by":"crossref","first-page":"2457","DOI":"10.2337\/dc06-0360","article-title":"Plasma Retinol-Binding Protein-4 Concentrations Are Elevated in Human Subjects with Impaired Glucose Tolerance and Type 2 Diabetes","volume":"29","author":"Cho","year":"2006","journal-title":"Diabetes Care"},{"key":"ref_489","doi-asserted-by":"crossref","first-page":"1886","DOI":"10.1210\/jc.2006-1815","article-title":"Retinol-Binding Protein 4 Is Associated with Insulin Resistance and Body Fat Distribution in Nonobese Subjects without Type 2 Diabetes","volume":"92","author":"Gavi","year":"2007","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_490","doi-asserted-by":"crossref","first-page":"2552","DOI":"10.1056\/NEJMoa054862","article-title":"Retinol-Binding Protein 4 and Insulin Resistance in Lean, Obese, and Diabetic Subjects","volume":"354","author":"Graham","year":"2006","journal-title":"N. Engl. J. Med."},{"key":"ref_491","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1007\/s10753-010-9219-y","article-title":"Central Adiposity Rather Than Total Adiposity Measurements Are Specifically Involved in the Inflammatory Status from Healthy Young Adults","volume":"34","author":"Hermsdorff","year":"2010","journal-title":"Inflammation"},{"key":"ref_492","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1038\/oby.2009.328","article-title":"Retinol-binding Protein 4 (RBP4) Protein Expression Is Increased in Omental Adipose Tissue of Severely Obese Patients","volume":"18","author":"Kelly","year":"2009","journal-title":"Obesity"},{"key":"ref_493","doi-asserted-by":"crossref","first-page":"2590","DOI":"10.1210\/jc.2006-0816","article-title":"Retinol binding protein 4 expression in humans: Relationship to insulin resistance, inflammation, and response to pioglitazone","volume":"92","author":"Varma","year":"2007","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_494","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1507\/endocrj.K08E-030","article-title":"Abdominal Visceral Fat Reduction Is Associated with Favorable Changes of Serum Retinol Binding Protein-4 in Nondiabetic Subjects","volume":"55","author":"Lee","year":"2008","journal-title":"Endocr. J."},{"key":"ref_495","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.2337\/dc06-2034","article-title":"Circulating Retinol-Binding Protein-4, Insulin Sensitivity, Insulin Secretion, and Insulin Disposition Index in Obese and Nonobese Subjects","volume":"30","author":"Broch","year":"2007","journal-title":"Diabetes Care"},{"key":"ref_496","doi-asserted-by":"crossref","first-page":"57","DOI":"10.3109\/13813451003631421","article-title":"Association of serum levels of retinol-binding protein 4 with male sex but not with insulin resistance in obese patients","volume":"116","author":"Herder","year":"2010","journal-title":"Arch. Physiol. Biochem."},{"key":"ref_497","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1007\/s00125-007-0743-8","article-title":"Retinol-binding protein 4 is associated with components of the metabolic syndrome, but not with insulin resistance, in men with type 2 diabetes or coronary artery disease","volume":"50","author":"Lepper","year":"2007","journal-title":"Diabetologia"},{"key":"ref_498","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1007\/BF03346678","article-title":"Serum retinol binding protein 4 level is related with renal functions in Type 2 diabetes","volume":"33","author":"Akbay","year":"2010","journal-title":"J. Endocrinol. Investig."},{"key":"ref_499","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1530\/EJE-11-0431","article-title":"RBP4: A controversial adipokine","volume":"165","author":"Kotnik","year":"2011","journal-title":"Eur. J. Endocrinol."},{"key":"ref_500","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1038\/sj.ejcn.1600825","article-title":"Retinol, \u03b1-tocopherol and carotenoids in diabetes","volume":"53","author":"Abahusain","year":"1999","journal-title":"Eur. J. Clin. Nutr."},{"key":"ref_501","doi-asserted-by":"crossref","unstructured":"Rychter, A.M., Skrzypczak-Zieli\u0144ska, M., Zieli\u0144ska, A., Eder, P., Souto, E.B., Zawada, A., Ratajczak, A.E., Dobrowolska, A., and Krela-Ka\u017amierczak, I. (2020). Is the Retinol-Binding Protein 4 a Possible Risk Factor for Cardiovascular Diseases in Obesity?. Int. J. Mol. Sci., 21.","DOI":"10.32545\/encyclopedia202008.0009.v2"},{"key":"ref_502","doi-asserted-by":"crossref","first-page":"2199","DOI":"10.2337\/diabetes.50.10.2199","article-title":"Resistin\/Fizz3 Expression in Relation to Obesity and Peroxisome Proliferator-Activated Receptor- Action in Humans","volume":"50","author":"Savage","year":"2001","journal-title":"Diabetes"},{"key":"ref_503","doi-asserted-by":"crossref","first-page":"4848","DOI":"10.1210\/jc.2003-030519","article-title":"Circulating resistin levels are not associated with obesity or insulin resistance in humans and are not regulated by fasting or leptin administration: Cross-sectional and interventional studies in normal, insulin-resistant, and diabetic subjects","volume":"88","author":"Lee","year":"2003","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_504","doi-asserted-by":"crossref","first-page":"4335","DOI":"10.1210\/jc.2005-0293","article-title":"Increased Serum Resistin in Adults with Prader-Willi Syndrome Is Related to Obesity and Not to Insulin Resistance","volume":"90","author":"Pagano","year":"2005","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_505","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1161\/01.CIR.0000155620.10387.43","article-title":"Resistin Is an Inflammatory Marker of Atherosclerosis in Humans","volume":"111","author":"Reilly","year":"2005","journal-title":"Circulation"},{"key":"ref_506","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1253\/circj.71.868","article-title":"Serum Resistin as a Biological Marker for Coronary Artery Disease and Restenosis in Type 2 Diabetic Patients","volume":"71","author":"On","year":"2007","journal-title":"Circ. J."},{"key":"ref_507","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1055\/s-2007-985897","article-title":"Resistin- and Obesity-associated Metabolic Diseases","volume":"39","author":"Lazar","year":"2007","journal-title":"Horm. Metab. Res."},{"key":"ref_508","first-page":"259","article-title":"Human resistin: Found in translation from mouse to man","volume":"22","author":"Schwartz","year":"2011","journal-title":"Trends Endocrinol. Metab."},{"key":"ref_509","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.ymgme.2011.03.007","article-title":"Association between polymorphisms of the Nesfatin gene, NUCB2, and obesity in men","volume":"103","author":"Zegers","year":"2011","journal-title":"Mol. Genet. Metab."},{"key":"ref_510","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/j.ymgme.2012.10.014","article-title":"Identification of mutations in the NUCB2\/nesfatin gene in children with severe obesity","volume":"107","author":"Zegers","year":"2012","journal-title":"Mol. Genet. Metab."},{"key":"ref_511","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.gene.2012.12.017","article-title":"The association of a nucleobindin 2 gene (NUCB2) variant with childhood adiposity","volume":"516","author":"Chen","year":"2013","journal-title":"Gene"},{"key":"ref_512","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.regpep.2009.11.003","article-title":"Fasting plasma levels of nesfatin-1 in patients with type 1 and type 2 diabetes mellitus and the nutrient-related fluctuation of nesfatin-1 level in normal humans","volume":"159","author":"Li","year":"2010","journal-title":"Regul. Pept."},{"key":"ref_513","doi-asserted-by":"crossref","first-page":"404","DOI":"10.4093\/dmj.2013.37.6.404","article-title":"Resistin in rodents and humans","volume":"37","author":"Park","year":"2013","journal-title":"Diabetes Metab. J."},{"key":"ref_514","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.atherosclerosis.2014.12.044","article-title":"The association of resistin with cardiovascular disease in the Multi-Ethnic Study of Atherosclerosis","volume":"239","author":"Muse","year":"2015","journal-title":"Atherosclerosis"},{"key":"ref_515","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1111\/j.1476-5381.2011.01369.x","article-title":"Resistin: Functional roles and therapeutic considerations for cardiovascular disease","volume":"165","author":"Jamaluddin","year":"2012","journal-title":"Br. J. Pharmacol."},{"key":"ref_516","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1161\/CIRCULATIONAHA.105.543579","article-title":"CCL2 polymorphisms are associated with serum monocyte chemoattractant protein-1 levels and myocardial infarction in the Framingham Heart Study","volume":"112","author":"McDermott","year":"2005","journal-title":"Circulation"},{"key":"ref_517","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.cca.2009.01.025","article-title":"Circulating concentrations of monocyte chemoattractant protein-1 are associated with menopause status in Korean women","volume":"403","author":"Park","year":"2009","journal-title":"Clin. Chim. Acta"},{"key":"ref_518","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1001\/jamacardio.2020.5392","article-title":"Association of Circulating Monocyte Chemoattractant Protein\u20131 Levels with Cardiovascular Mortality: A Meta-analysis of Population-Based Studies","volume":"6","author":"Georgakis","year":"2021","journal-title":"JAMA Cardiol."},{"key":"ref_519","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1373\/clinchem.2006.075614","article-title":"Lipocalin-2 is an inflammatory marker closely associated with obesity, insulin resistance, and hyperglycemia in humans","volume":"53","author":"Wang","year":"2007","journal-title":"Clin. Chem."},{"key":"ref_520","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1007\/s00109-009-0486-8","article-title":"Increased adipose tissue expression of lipocalin-2 in obesity is related to inflammation and matrix metalloproteinase-2 and metalloproteinase-9 activities in humans","volume":"87","author":"Silva","year":"2009","journal-title":"J. Mol. Med."},{"key":"ref_521","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1016\/j.ejvs.2022.01.012","article-title":"Lipocalin-2 and Calprotectin Potential Prognosis Biomarkers in Peripheral Arterial Disease","volume":"63","author":"Ravassa","year":"2022","journal-title":"Eur. J. Vasc. Endovasc. Surg."},{"key":"ref_522","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.2337\/dc09-0476","article-title":"Transforming Growth Factor- 1 and Incident Type 2 Diabetes: Results from the MONICA\/KORA case-cohort study, 1984\u20132002","volume":"32","author":"Herder","year":"2009","journal-title":"Diabetes Care"},{"key":"ref_523","doi-asserted-by":"crossref","first-page":"2525","DOI":"10.2337\/db08-1261","article-title":"Interleukin-10 prevents diet-induced insulin resistance by attenuating macrophage and cytokine response in skeletal muscle","volume":"58","author":"Hong","year":"2009","journal-title":"Diabetes"},{"key":"ref_524","doi-asserted-by":"crossref","first-page":"2338","DOI":"10.1161\/ATVBAHA.111.231795","article-title":"Circulating Interleukin-10 and Risk of Cardiovascular Events: A Prospective Study in the Elderly at Risk","volume":"31","author":"Welsh","year":"2011","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_525","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1530\/EJE-09-0380","article-title":"Chemerin is associated with markers of inflammation and components of the metabolic syndrome but does not predict coronary atherosclerosis","volume":"161","author":"Lehrke","year":"2009","journal-title":"Eur. J. Endocrinol."},{"key":"ref_526","doi-asserted-by":"crossref","first-page":"4687","DOI":"10.1210\/en.2007-0175","article-title":"Chemerin Is a Novel Adipokine Associated with Obesity and Metabolic Syndrome","volume":"148","author":"Bozaoglu","year":"2007","journal-title":"Endocrinology"},{"key":"ref_527","doi-asserted-by":"crossref","first-page":"E514","DOI":"10.1210\/jc.2012-3673","article-title":"Increased Chemerin and Decreased Omentin-1 in Both Adipose Tissue and Plasma in Nascent Metabolic Syndrome","volume":"98","author":"Jialal","year":"2013","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_528","doi-asserted-by":"crossref","first-page":"2892","DOI":"10.1210\/jc.2009-2374","article-title":"Chemerin Correlates with Markers for Fatty Liver in Morbidly Obese Patients and Strongly Decreases after Weight Loss Induced by Bariatric Surgery","volume":"95","author":"Sell","year":"2010","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_529","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.jacc.2018.10.058","article-title":"Chemerin as a Biomarker Linking Inflammation and Cardiovascular Diseases","volume":"73","author":"Eichelmann","year":"2019","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_530","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.2337\/db09-1199","article-title":"Accelerated increase in serum interleukin-1 receptor antagonist starts 6 years before diagnosis of type 2 diabetes: Whitehall II prospective cohort study","volume":"59","author":"Carstensen","year":"2010","journal-title":"Diabetes"},{"key":"ref_531","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.diabres.2012.11.026","article-title":"Plasma SFRP5 levels are decreased in Chinese subjects with obesity and type 2 diabetes and negatively correlated with parameters of insulin resistance","volume":"99","author":"Hu","year":"2013","journal-title":"Diabetes Res. Clin. Pract."},{"key":"ref_532","doi-asserted-by":"crossref","first-page":"E503","DOI":"10.1210\/jc.2012-3416","article-title":"Characterization of the Wnt Inhibitors Secreted Frizzled-Related Proteins (SFRPs) in Human Adipose Tissue","volume":"98","author":"Ehrlund","year":"2013","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_533","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1111\/dom.12155","article-title":"Anti-inflammatory cytokines and risk of type 2 diabetes","volume":"15","author":"Herder","year":"2013","journal-title":"Diabetes Obes. Metab."},{"key":"ref_534","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1074\/jbc.M111.261818","article-title":"Fat-derived factor omentin stimulates endothelial cell function and ischemia-induced revascularization via endothelial nitric oxide synthase-dependent mechanism","volume":"287","author":"Maruyama","year":"2012","journal-title":"J. Biol. Chem."},{"key":"ref_535","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1055\/s-0030-1269912","article-title":"Changes of Serum Omentin Levels and Relationship between Omentin and Adiponectin Concentrations in Type 2 Diabetes Mellitus","volume":"119","author":"Yan","year":"2011","journal-title":"Exp. Clin. Endocrinol. Diabetes"},{"key":"ref_536","doi-asserted-by":"crossref","first-page":"946427","DOI":"10.1155\/2013\/946427","article-title":"Visfatin\/Nampt: An adipokine with cardiovascular impact","volume":"2013","author":"Romacho","year":"2013","journal-title":"Mediat. Inflamm."},{"key":"ref_537","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1210\/jc.2006-1303","article-title":"Human visfatin expression: Relationship to insulin sensitivity, intramyocellular lipids, and inflammation","volume":"92","author":"Varma","year":"2007","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_538","doi-asserted-by":"crossref","unstructured":"Cavallo, M.G., Sentinelli, F., Barchetta, I., Costantino, C., Incani, M., Perra, L., Capoccia, D., Romeo, S., Cossu, E., and Leonetti, F. (2012). Altered glucose homeostasis is associated with increased serum apelin levels in type 2 diabetes mellitus. PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0051236"},{"key":"ref_539","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.1007\/s00018-013-1258-8","article-title":"Vaspin inhibits kallikrein 7 by serpin mechanism","volume":"70","author":"Heiker","year":"2013","journal-title":"Cell. Mol. Life Sci."},{"key":"ref_540","doi-asserted-by":"crossref","first-page":"33293","DOI":"10.1074\/jbc.R100016200","article-title":"The Serpins Are an Expanding Superfamily of Structurally Similar but Functionally Diverse Proteins: Evolution, Mechanism of Inhibition, Novel Functions, and a Revised Nomenclature","volume":"276","author":"Silverman","year":"2001","journal-title":"J. Biol. Chem."},{"key":"ref_541","doi-asserted-by":"crossref","first-page":"E1202","DOI":"10.1210\/jc.2011-3297","article-title":"Serum Vaspin Concentrations Are Closely Related to Insulin Resistance, and rs77060950 atSERPINA12Genetically Defines Distinct Group with Higher Serum Levels in Japanese Population","volume":"97","author":"Teshigawara","year":"2012","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_542","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1007\/s12020-013-9923-0","article-title":"Multi-functional peptide hormone NUCB2\/nesfatin-1","volume":"44","author":"Aydin","year":"2013","journal-title":"Endocrine"},{"key":"ref_543","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1111\/j.1365-2265.2010.03835.x","article-title":"Fasting Concentrations of Nesfatin-1 Are Negatively Correlated with Body Mass Index in Non-Obese Males","volume":"73","author":"Tsuchiya","year":"2010","journal-title":"Clin. Endocrinol."},{"key":"ref_544","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.2337\/db10-1707","article-title":"Dipeptidyl Peptidase 4 Is a Novel Adipokine Potentially Linking Obesity to the Metabolic Syndrome","volume":"60","author":"Lamers","year":"2011","journal-title":"Diabetes"},{"key":"ref_545","doi-asserted-by":"crossref","first-page":"E2018","DOI":"10.1210\/jc.2011-1497","article-title":"The roles of IL-6, IL-10, and IL-1RA in obesity and insulin resistance in African-Americans","volume":"96","author":"Charles","year":"2011","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_546","doi-asserted-by":"crossref","unstructured":"Lehrke, M., Reilly, M.P., Millington, S.C., Iqbal, N., Rader, D.J., and Lazar, M.A. (2004). An Inflammatory Cascade Leading to Hyperresistinemia in Humans. PLoS Med., 1.","DOI":"10.1371\/journal.pmed.0010045"},{"key":"ref_547","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1007\/s12013-011-9209-1","article-title":"Interleukin-6, but not soluble adhesion molecules, predicts a subsequent mortality from cardiovascular disease in patients with acute ST-segment elevation myocardial infarction","volume":"61","author":"Fan","year":"2011","journal-title":"Cell Biochem. Biophys."},{"key":"ref_548","doi-asserted-by":"crossref","first-page":"166170","DOI":"10.1016\/j.bbadis.2021.166170","article-title":"VCAM-1 as a predictor biomarker in cardiovascular disease","volume":"1867","author":"Troncoso","year":"2021","journal-title":"Biochim. Biophys. Acta (BBA)-Mol. Basis Dis."},{"key":"ref_549","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1161\/01.ATV.21.4.473","article-title":"Paraoxonase and atherosclerosis","volume":"21","author":"Durrington","year":"2001","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_550","doi-asserted-by":"crossref","first-page":"3957","DOI":"10.1074\/jbc.275.6.3957","article-title":"Calcium-dependent human serum homocysteine thiolactone hydrolase. A protective mechanism against protein N-homocysteinylation","volume":"275","author":"Jakubowski","year":"2000","journal-title":"J. Biol. Chem."},{"key":"ref_551","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1016\/S0891-5849(98)00272-X","article-title":"Human serum paraoxonase (PON 1) is inactivated by oxidized low density lipoprotein and preserved by antioxidants","volume":"26","author":"Aviram","year":"1999","journal-title":"Free Radic. Biol. Med."},{"key":"ref_552","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/S0021-9150(98)00084-7","article-title":"Paraoxonase activity in the serum and hepatic mRNA levels decrease during the acute phase response","volume":"139","author":"Feingold","year":"1998","journal-title":"Atherosclerosis"},{"key":"ref_553","doi-asserted-by":"crossref","first-page":"160","DOI":"10.3109\/13506120209114817","article-title":"Proinflammatory cytokines but not acute phase serum amyloid A or C-reactive protein, downregulate paraoxonase 1 (PON1) expression by HepG2 cells","volume":"9","author":"Kumon","year":"2002","journal-title":"Amyloid"},{"key":"ref_554","doi-asserted-by":"crossref","first-page":"2807","DOI":"10.1016\/S0024-3205(03)00704-5","article-title":"Human paraoxonase-1 gene expression by HepG2 cells is downregulated by interleukin-1beta and tumor necrosis factor-alpha, but is upregulated by interleukin-6","volume":"73","author":"Kumon","year":"2003","journal-title":"Life Sci."},{"key":"ref_555","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1074\/jbc.M004074200","article-title":"Oxidized phospholipids induce changes in hepatic paraoxonase and ApoJ but not monocyte chemoattractant protein-1 via interleukin-6","volume":"276","author":"Wagner","year":"2001","journal-title":"J. Biol. Chem."},{"key":"ref_556","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.1210\/jc.2004-0486","article-title":"Paraoxonase activity in high-density lipoproteins: A comparison between healthy and obese females","volume":"90","author":"Ferretti","year":"2005","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_557","doi-asserted-by":"crossref","first-page":"211","DOI":"10.2165\/00129784-200404040-00002","article-title":"The role of paraoxonase 1 activity in cardiovascular disease: Potential for therapeutic intervention","volume":"4","author":"Mackness","year":"2004","journal-title":"Am. J. Cardiovasc. Drugs"},{"key":"ref_558","doi-asserted-by":"crossref","first-page":"2082","DOI":"10.1681\/ASN.V9112082","article-title":"Decrease of serum paraoxonase activity in chronic renal failure","volume":"9","author":"Dantoine","year":"1998","journal-title":"J. Am. Soc. Nephrol. JASN"},{"key":"ref_559","doi-asserted-by":"crossref","first-page":"2264","DOI":"10.1210\/jc.2004-1295","article-title":"Small, dense lipoprotein particles and reduced paraoxonase-1 in patients with the metabolic syndrome","volume":"90","author":"Garin","year":"2005","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_560","doi-asserted-by":"crossref","first-page":"2957","DOI":"10.1210\/jc.2003-031897","article-title":"Protective effect of paraoxonase activity in high-density lipoproteins against erythrocyte membranes peroxidation: A comparison between healthy subjects and type 1 diabetic patients","volume":"89","author":"Ferretti","year":"2004","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_561","doi-asserted-by":"crossref","first-page":"1812","DOI":"10.1161\/01.ATV.15.11.1812","article-title":"Serum paraoxonase activity, concentration, and phenotype distribution in diabetes mellitus and its relationship to serum lipids and lipoproteins","volume":"15","author":"Abbott","year":"1995","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_562","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1111\/j.1399-0004.1991.tb03096.x","article-title":"Influence of serum paraoxonase polymorphism on serum lipids and apolipoproteins","volume":"40","author":"Saha","year":"1991","journal-title":"Clin. Genet."},{"key":"ref_563","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/s10238-005-0072-5","article-title":"Effect of different levels of cigarette smoking on lipid peroxidation, glutathione enzymes and paraoxonase 1 activity in healthy people","volume":"5","author":"Solak","year":"2005","journal-title":"Clin. Exp. Med."},{"key":"ref_564","doi-asserted-by":"crossref","first-page":"2252","DOI":"10.1161\/01.CIR.101.19.2252","article-title":"Smoking Is Associated with Reduced Serum Paraoxonase Activity and Concentration in Patients with Coronary Artery Disease","volume":"101","author":"James","year":"2000","journal-title":"Circulation"},{"key":"ref_565","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1093\/clinchem\/48.2.261","article-title":"Serum paraoxonase activity: A new additional test for the improved evaluation of chronic liver damage","volume":"48","author":"Ferre","year":"2002","journal-title":"Clin. Chem."},{"key":"ref_566","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.1161\/01.ATV.0000096207.01487.36","article-title":"Simvastatin modulates expression of the PON1 gene and increases serum paraoxonase: A role for sterol regulatory element-binding protein-2","volume":"23","author":"Deakin","year":"2003","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_567","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1172\/JCI111133","article-title":"Effect of fatty acids on glucose production and utilization in man","volume":"72","author":"Ferrannini","year":"1983","journal-title":"J. Clin. Investig."},{"key":"ref_568","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1002\/oby.20329","article-title":"IGF-I attenuates FFA-induced activation of JNK1 phosphorylation and TNFalpha expression in human subcutaneous preadipocytes","volume":"21","author":"Neacsu","year":"2013","journal-title":"Obesity"},{"key":"ref_569","doi-asserted-by":"crossref","first-page":"3","DOI":"10.2337\/diab.46.1.3","article-title":"Role of fatty acids in the pathogenesis of insulin resistance and NIDDM","volume":"46","author":"Boden","year":"1997","journal-title":"Diabetes"},{"key":"ref_570","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.tem.2007.10.006","article-title":"Location, location: Protein trafficking and lipolysis in adipocytes","volume":"19","author":"Granneman","year":"2008","journal-title":"Trends Endocrinol. Metab."},{"key":"ref_571","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1126\/science.1100747","article-title":"Fat Mobilization in Adipose Tissue Is Promoted by Adipose Triglyceride Lipase","volume":"306","author":"Zimmermann","year":"2004","journal-title":"Science"},{"key":"ref_572","doi-asserted-by":"crossref","first-page":"E1847","DOI":"10.1152\/ajpendo.00040.2007","article-title":"Comparative studies of the role of hormone-sensitive lipase and adipose triglyceride lipase in human fat cell lipolysis","volume":"292","author":"Ryden","year":"2007","journal-title":"AJP Endocrinol. Metab."},{"key":"ref_573","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1172\/JCI5001","article-title":"Effects of free fatty acids on glucose transport and IRS-1\u2013associated phosphatidylinositol 3-kinase activity","volume":"103","author":"Dresner","year":"1999","journal-title":"J. Clin. Investig."},{"key":"ref_574","doi-asserted-by":"crossref","first-page":"48115","DOI":"10.1074\/jbc.M209459200","article-title":"Serine Phosphorylation of Insulin Receptor Substrate 1 by Inhibitor B Kinase Complex","volume":"277","author":"Gao","year":"2002","journal-title":"J. Biol. Chem."},{"key":"ref_575","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1038\/nature01137","article-title":"A central role for JNK in obesity and insulin resistance","volume":"420","author":"Hirosumi","year":"2002","journal-title":"Nature"},{"key":"ref_576","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1172\/JCI200422230","article-title":"PKC-\u03b8 knockout mice are protected from fat-induced insulin resistance","volume":"114","author":"Kim","year":"2004","journal-title":"J. Clin. Investig."},{"key":"ref_577","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/j.cmet.2007.09.011","article-title":"JNK1 in Hematopoietically Derived Cells Contributes to Diet-Induced Inflammation and Insulin Resistance without Affecting Obesity","volume":"6","author":"Solinas","year":"2007","journal-title":"Cell Metab."},{"key":"ref_578","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1038\/nature02866","article-title":"Absence of S6K1 protects against age- and diet-induced obesity while enhancing insulin sensitivity","volume":"431","author":"Um","year":"2004","journal-title":"Nature"},{"key":"ref_579","doi-asserted-by":"crossref","first-page":"26865","DOI":"10.1074\/jbc.M513304200","article-title":"Toll-like Receptor-2 Is Essential for the Development of Palmitate-induced Insulin Resistance in Myotubes","volume":"281","author":"Senn","year":"2006","journal-title":"J. Biol. Chem."},{"key":"ref_580","doi-asserted-by":"crossref","first-page":"3015","DOI":"10.1172\/JCI28898","article-title":"TLR4 links innate immunity and fatty acid\u2013induced insulin resistance","volume":"116","author":"Shi","year":"2006","journal-title":"J. Clin. Investig."},{"key":"ref_581","doi-asserted-by":"crossref","first-page":"S189","DOI":"10.1055\/s-2001-18581","article-title":"The role of lipids in the pathogenesis of muscle insulin resistance and beta cell failure in type II diabetes and obesity","volume":"109","author":"Kraegen","year":"2001","journal-title":"Exp. Clin. Endocrinol. Diabetes"},{"key":"ref_582","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.1172\/JCI200319246","article-title":"Obesity is associated with macrophage accumulation in adipose tissue","volume":"112","author":"Weisberg","year":"2003","journal-title":"J. Clin. Investig."},{"key":"ref_583","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1073\/pnas.0507660103","article-title":"An RNA interference-based screen identifies MAP4K4\/NIK as a negative regulator of PPAR, adipogenesis, and insulin-responsive hexose transport","volume":"103","author":"Tang","year":"2006","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_584","first-page":"1457","article-title":"Negative regulation of peroxisome proliferator-activated receptor-gamma gene expression contributes to the antiadipogenic effects of tumor necrosis factor-alpha","volume":"10","author":"Zhang","year":"1996","journal-title":"Mol. Endocrinol."},{"key":"ref_585","doi-asserted-by":"crossref","first-page":"2547","DOI":"10.1194\/jlr.R700014-JLR200","article-title":"Thematic review series: Adipocyte Biology. The perilipin family of structural lipid droplet proteins: Stabilization of lipid droplets and control of lipolysis","volume":"48","author":"Brasaemle","year":"2007","journal-title":"J. Lipid Res."},{"key":"ref_586","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1073\/pnas.0708579105","article-title":"Evolutionarily conserved gene family important for fat storage","volume":"105","author":"Kadereit","year":"2007","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_587","doi-asserted-by":"crossref","first-page":"3418","DOI":"10.2337\/db06-0399","article-title":"OXPAT\/PAT-1 Is a PPAR-Induced Lipid Droplet Protein That Promotes Fatty Acid Utilization","volume":"55","author":"Wolins","year":"2006","journal-title":"Diabetes"},{"key":"ref_588","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1038\/nrm2391","article-title":"Adipocyte dysfunctions linking obesity to insulin resistance and type 2 diabetes","volume":"9","author":"Guilherme","year":"2008","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"ref_589","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1161\/ATVBAHA.107.160739","article-title":"Cardiovascular events with increased lipoprotein-associated phospholipase A(2) and low high-density lipoprotein-cholesterol: The Veterans Affairs HDL Intervention Trial","volume":"28","author":"Robins","year":"2008","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_590","doi-asserted-by":"crossref","unstructured":"Geller, F., Dempfle, A., Gorg, T., and Framingham Heart Study (2003). Genome scan for body mass index and height in the Framingham Heart Study. BMC Genet., 4.","DOI":"10.1186\/1471-2156-4-S1-S91"},{"key":"ref_591","doi-asserted-by":"crossref","first-page":"2855","DOI":"10.1161\/CIRCULATIONAHA.110.974899","article-title":"Genome-wide association study for coronary artery calcification with follow-up in myocardial infarction","volume":"124","author":"Kavousi","year":"2011","journal-title":"Circulation"},{"key":"ref_592","doi-asserted-by":"crossref","unstructured":"Pinnaduwage, D., Beyene, J., and Fallah, S. (2003). Genome-wide linkage analysis of systolic blood pressure slope using the Genetic Analysis Workshop 13 data sets. BMC Genet., 4.","DOI":"10.1186\/1471-2156-4-S1-S86"},{"key":"ref_593","doi-asserted-by":"crossref","first-page":"3063","DOI":"10.2337\/db07-0451","article-title":"A 100K genome-wide association scan for diabetes and related traits in the Framingham Heart Study: Replication and integration with other genome-wide datasets","volume":"56","author":"Florez","year":"2007","journal-title":"Diabetes"},{"key":"ref_594","doi-asserted-by":"crossref","first-page":"2364","DOI":"10.1016\/j.jacc.2012.09.007","article-title":"Relations of long-term and contemporary lipid levels and lipid genetic risk scores with coronary artery calcium in the framingham heart study","volume":"60","author":"Tsao","year":"2012","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_595","doi-asserted-by":"crossref","unstructured":"Cupples, L.A., Arruda, H.T., Benjamin, E.J., D\u2019Agostino, R.B., Sr Demissie, S., DeStefano, A.L., Dupuis, J., Falls, K.M., Fox, C.S., and Gottlieb, D.J. (2007). The Framingham Heart Study 100K SNP genome-wide association study resource: Overview of 17 phenotype working group reports. BMC Med. Genet., 8.","DOI":"10.1186\/1471-2350-8-S1-S1"},{"key":"ref_596","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1038\/s44161-024-00567-0","article-title":"Integrative proteomic analyses across common cardiac diseases yield mechanistic insights and enhanced prediction","volume":"3","author":"Schuermans","year":"2024","journal-title":"Nat. Cardiovasc. Res."},{"key":"ref_597","doi-asserted-by":"crossref","first-page":"eabj9625","DOI":"10.1126\/scitranslmed.abj9625","article-title":"A proteomic surrogate for cardiovascular outcomes that is sensitive to multiple mechanisms of change in risk","volume":"14","author":"Williams","year":"2022","journal-title":"Sci. Transl. Med."},{"key":"ref_598","first-page":"1861","article-title":"Combined clinical, metabolomic, and polygenic scores for cardiovascular risk prediction","volume":"47","author":"Ritchie","year":"2025","journal-title":"Eur. Heart J."}],"container-title":["Journal of Cardiovascular Development and Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2308-3425\/13\/8\/358\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T11:13:43Z","timestamp":1785755623000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2308-3425\/13\/8\/358"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,29]]},"references-count":598,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2026,8]]}},"alternative-id":["jcdd13080358"],"URL":"https:\/\/doi.org\/10.3390\/jcdd13080358","relation":{},"ISSN":["2308-3425"],"issn-type":[{"value":"2308-3425","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,29]]}}}